Leif Mosekilde - publications

1: Við Streym S, Højskov CS, Møller UK, Heickendorff L, Vestergaard P, Mosekilde 
L, Rejnmark L. Vitamin D content in human breast milk: a 9-mo follow-up study. Am
J Clin Nutr. 2016 Jan;103(1):107-14. doi: 10.3945/ajcn.115.115105. Epub 2015 Dec 
16. PubMed PMID: 26675779.


2: Greibe E, Lildballe DL, Streym S, Vestergaard P, Rejnmark L, Mosekilde L, Nexo
E. Cobalamin and haptocorrin in human milk and cobalamin-related variables in
mother and child: a 9-mo longitudinal study. Am J Clin Nutr. 2013
Aug;98(2):389-95. doi: 10.3945/ajcn.113.058479. PubMed PMID: 23783295.


3: Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L,
Mosekilde L. Reduced prediagnostic 25-hydroxyvitamin D levels in women with
breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev.
2009 Oct;18(10):2655-60. doi: 10.1158/1055-9965.EPI-09-0531. Epub 2009 Sep 29.
PubMed PMID: 19789365.


4: Møller UK, Jensen LT, Mosekilde L, Rejnmark L. Effects of adding chymosin to
milk on calcium homeostasis: a randomized, double-blind, cross-over study. Calcif
Tissue Int. 2015 Feb;96(2):105-12. doi: 10.1007/s00223-014-9942-8. Epub 2014 Dec 
18. PubMed PMID: 25515208.


5: Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L,
Christiansen P. Vitamin D treatment in primary hyperparathyroidism: a randomized 
placebo controlled trial. J Clin Endocrinol Metab. 2014 Mar;99(3):1072-80. doi:
10.1210/jc.2013-3978. Epub 2014 Jan 13. PubMed PMID: 24423366.


6: Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. The effect of melatonin
treatment on postural stability, muscle strength, and quality of life and sleep
in postmenopausal women: a randomized controlled trial. Nutr J. 2015 Sep
30;14:102. doi: 10.1186/s12937-015-0093-1. PubMed PMID: 26424587; PubMed Central 
PMCID: PMC4590707.




7: Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Determinants of plasma
PTH and their implication for defining a reference interval. Clin Endocrinol
(Oxf). 2011 Jan;74(1):37-43. doi: 10.1111/j.1365-2265.2010.03894.x. PubMed PMID: 
21039730.


8: Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde 
L. Discriminative power of three indices of renal calcium excretion for the
distinction between familial hypocalciuric hypercalcaemia and primary
hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf). 2008
Nov;69(5):713-20. doi: 10.1111/j.1365-2265.2008.03259.x. Epub 2008 Apr 10. PubMed
PMID: 18410554.


9: Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L,
Christiansen P. No beneficial effects of vitamin D supplementation on muscle
function or quality of life in primary hyperparathyroidism: results from a
randomized controlled trial. Eur J Endocrinol. 2015 May;172(5):609-17. doi:
10.1530/EJE-14-0940. Epub 2015 Feb 2. PubMed PMID: 25646406.


10: Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and
hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002
May;12(5):411-9. PubMed PMID: 12097203.


11: Gissel T, Rejnmark L, Mosekilde L, Vestergaard P. Intake of vitamin D and
risk of breast cancer--a meta-analysis. J Steroid Biochem Mol Biol. 2008
Sep;111(3-5):195-9. doi: 10.1016/j.jsbmb.2008.06.002. Epub 2008 Jun 11. PubMed
PMID: 18590821.


12: Andersen S, Laurberg P, Hvingel B, Kleinschmidt K, Heickendorff L, Mosekilde 
L. Vitamin D status in Greenland is influenced by diet and ethnicity: a
population-based survey in an Arctic society in transition. Br J Nutr. 2013 Mar
14;109(5):928-35. doi: 10.1017/S0007114512002097. Epub 2012 Jun 8. PubMed PMID:
22682501.


13: Møller UK, Streym Sv, Jensen LT, Mosekilde L, Schoenmakers I, Nigdikar S,
Rejnmark L. Increased plasma concentrations of vitamin D metabolites and vitamin 
D binding protein in women using hormonal contraceptives: a cross-sectional
study. Nutrients. 2013 Sep 5;5(9):3470-80. doi: 10.3390/nu5093470. PubMed PMID:
24013463; PubMed Central PMCID: PMC3798915.


14: Amstrup AK, Sikjaer T, Pedersen SB, Heickendorff L, Mosekilde L, Rejnmark L. 
Reduced fat mass and increased lean mass in response to 1 year of melatonin
treatment in postmenopausal women: A randomized placebo-controlled trial. Clin
Endocrinol (Oxf). 2015 Sep 9. doi: 10.1111/cen.12942. [Epub ahead of print]
PubMed PMID: 26352863.


15: Vestergaard P, Rejnmark L, Mosekilde L. High-dose treatment with vitamin A
analogues and risk of fractures. Arch Dermatol. 2010 May;146(5):478-82. doi:
10.1001/archdermatol.2010.59. PubMed PMID: 20479294.


16: Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Simvastatin does not 
affect vitamin d status, but low vitamin d levels are associated with
dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol.
2010;2010:957174. doi: 10.1155/2010/957174. Epub 2009 Jul 21. PubMed PMID:
20016680; PubMed Central PMCID: PMC2778175.


17: Rejnmark L, Vestergaard P, Mosekilde L. Pre-existing diseases and use of loop
diuretics may explain increased mortality in secondary hyperparathyroidism. Clin 
Endocrinol (Oxf). 2008 Sep;69(3):514. doi: 10.1111/j.1365-2265.2008.03223.x. Epub
2008 Feb 13. PubMed PMID: 18284642.


18: Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Plasma 1,25(OH)2D
levels decrease in postmenopausal women with hypovitaminosis D. Eur J Endocrinol.
2008 Apr;158(4):571-6. doi: 10.1530/EJE-07-0844. PubMed PMID: 18362305.


19: Vestergaard P, Støen OG, Swenson JE, Mosekilde L, Heickendorff L, Fröbert O. 
Vitamin D status and bone and connective tissue turnover in brown bears (Ursus
arctos) during hibernation and the active state. PLoS One. 2011;6(6):e21483. doi:
10.1371/journal.pone.0021483. Epub 2011 Jun 23. PubMed PMID: 21731765; PubMed
Central PMCID: PMC3121767.


20: Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen 
K, Mosekilde L. Skeletal consequences of familial hypocalciuric hypercalcaemia
vs. primary hyperparathyroidism. Clin Endocrinol (Oxf). 2009 Dec;71(6):798-807.
doi: 10.1111/j.1365-2265.2009.03557.x. Epub 2009 Feb 25. PubMed PMID: 19250271.


21: Mosekilde L, Vestergaard P, Rejnmark L. The pathogenesis, treatment and
prevention of osteoporosis in men. Drugs. 2013 Jan;73(1):15-29. doi:
10.1007/s40265-012-0003-1. Review. PubMed PMID: 23329464.


22: Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics and sedatives and risk of
fractures: effects of half-life. Calcif Tissue Int. 2008 Jan;82(1):34-43. doi:
10.1007/s00223-007-9095-0. Epub 2008 Jan 4. PubMed PMID: 18175030.


23: Rejnmark L, Lauridsen AL, Vestergaard P, Heickendorff L, Andreasen F,
Mosekilde L. Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin
D-binding protein in postmenopausal women: relationship to plasma parathyroid
hormone and calcium and phosphate metabolism. Eur J Endocrinol. 2002
May;146(5):635-42. PubMed PMID: 11980618.


24: Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Increased fracture risk in
normocalcemic postmenopausal women with high parathyroid hormone levels: a
16-year follow-up study. Calcif Tissue Int. 2011 Mar;88(3):238-45. doi:
10.1007/s00223-010-9454-0. Epub 2010 Dec 23. PubMed PMID: 21181400.


25: Vestergaard P, Rejnmark L, Mosekilde L. Are antiresorptive drugs effective
against fractures in patients with diabetes? Calcif Tissue Int. 2011
Mar;88(3):209-14. doi: 10.1007/s00223-010-9450-4. Epub 2010 Dec 16. PubMed PMID: 
21161194.


26: Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L. Further
insights into the pathogenesis of primary hyperparathyroidism: a nested
case-control study. J Clin Endocrinol Metab. 2013 Jan;98(1):87-96. doi:
10.1210/jc.2012-2499. Epub 2012 Nov 12. PubMed PMID: 23150677.


27: Rejnmark L, Vestergaard P, Mosekilde L. Decreased fracture risk in users of
organic nitrates: a nationwide case-control study. J Bone Miner Res. 2006
Nov;21(11):1811-7. PubMed PMID: 17054422.


28: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Pseudohypoparathyroidism - 
epidemiology, mortality and risk of complications. Clin Endocrinol (Oxf). 2015
Sep 21. doi: 10.1111/cen.12948. [Epub ahead of print] PubMed PMID: 26387561.


29: Vestergaard P, Rejnmark L, Mosekilde L. Has mortality after a hip fracture
increased? J Am Geriatr Soc. 2007 Nov;55(11):1720-6. Epub 2007 Oct 3. PubMed
PMID: 17916118.


30: Vestergaard P, Mosekilde L. [No effect of calcium supplementation on bone
mineral density in children. Survey of a Cochrane review]. Ugeskr Laeger. 2007
Jun 25;169(26):2512-5. Review. Danish. PubMed PMID: 17725895.


31: Rejnmark L, Mosekilde L. New and emerging antiresorptive treatments in
osteoporosis. Curr Drug Saf. 2011 Apr;6(2):75-88. Review. PubMed PMID: 21524247.


32: Vestergaard P, Rejnmark L, Mosekilde L. The effects of depot
medroxyprogesterone acetate and intrauterine device use on fracture risk in
Danish women. Contraception. 2008 Dec;78(6):459-64. doi:
10.1016/j.contraception.2008.07.014. Epub 2008 Sep 10. PubMed PMID: 19014791.


33: Vestergaard P, Rejnmark L, Mosekilde L. [Osteoporosis and fractures
associated with drugs]. Ugeskr Laeger. 2008 Apr 28;170(18):1550-5. Review.
Danish. PubMed PMID: 18454925.


34: Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L. Melatonin
improves bone mineral density at the femoral neck in postmenopausal women with
osteopenia: a randomized controlled trial. J Pineal Res. 2015 Sep;59(2):221-9.
doi: 10.1111/jpi.12252. Epub 2015 Jun 24. PubMed PMID: 26036434.


35: Vestergaard P, Rejnmark L, Mosekilde L. [Strongly increasing incidence of hip
fractures in Denmark from 1977 to 1999]. Ugeskr Laeger. 2008 Feb 18;170(8):621-3.
Danish. PubMed PMID: 18367043.


36: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with
parkinsonism and anti-Parkinson drugs. Calcif Tissue Int. 2007 Sep;81(3):153-61. 
Epub 2007 Aug 20. PubMed PMID: 17705047.


37: Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L;
Hypoparathyroid Study Group. The effect of adding PTH(1-84) to conventional
treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone
Miner Res. 2011 Oct;26(10):2358-70. doi: 10.1002/jbmr.470. PubMed PMID: 21773992.


38: Vestergaard P, Mosekilde L. [Medical treatment of patients with primary
hyperparathyroidism]. Ugeskr Laeger. 2009 Aug 10;171(33):2284-7. Danish. PubMed
PMID: 19732508.


39: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Gastric and
esophagus events before and during treatment of osteoporosis. Calcif Tissue Int. 
2010 Feb;86(2):110-5. doi: 10.1007/s00223-009-9323-x. Epub 2009 Dec 3. PubMed
PMID: 19957165.


40: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal
complications to postsurgical hypoparathyroidism: a Danish nationwide controlled 
historic follow-up study. J Bone Miner Res. 2013 Nov;28(11):2277-85. doi:
10.1002/jbmr.1979. PubMed PMID: 23661265.


41: Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen 
K, Mosekilde L. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and
parathyroid hormone in familial hypocalciuric hypercalcemia and primary
hyperparathyroidism. Eur J Endocrinol. 2008 Dec;159(6):719-27. doi:
10.1530/EJE-08-0440. Epub 2008 Sep 11. PubMed PMID: 18787045.


42: Amstrup AK, Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Effects
of smoking on severity of disease in primary hyperparathyroidism. Calcif Tissue
Int. 2010 Nov;87(5):406-13. doi: 10.1007/s00223-010-9416-6. Epub 2010 Sep 23.
PubMed PMID: 20862465.


43: Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture
risk--a meta-analysis. Thyroid. 2003 Jun;13(6):585-93. Review. PubMed PMID:
12930603.


44: Amstrup AK, Rejnmark L, Vestergaard P, Sikjaer T, Rolighed L, Heickendorff L,
Mosekilde L. Vitamin D status, physical performance and body mass in patients
surgically cured for primary hyperparathyroidism compared with healthy controls -
a cross-sectional study. Clin Endocrinol (Oxf). 2011 Jan;74(1):130-6. doi:
10.1111/j.1365-2265.2010.03906.x. PubMed PMID: 21044111.


45: Vestergaard P, Schwartz K, Rejnmark L, Mosekilde L, Pinholt EM. Oral
bisphosphonate use increases the risk for inflammatory jaw disease: a cohort
study. J Oral Maxillofac Surg. 2012 Apr;70(4):821-9. doi:
10.1016/j.joms.2011.02.093. Epub 2011 Jul 20. PubMed PMID: 21764202.


46: Mosekilde L, Langdahl BL, Nielsen LR, Vestergaard P. [The usefulness of
calcium and vitamin D supplementation after the Women's Health Initiative trial].
Ugeskr Laeger. 2007 Sep 24;169(39):3273-6. Review. Danish. PubMed PMID: 17953883.


47: Rejnmark L, Vestergaard P, Mosekilde L. [Denosumab--a new efficient
osteoporosis therapy]. Ugeskr Laeger. 2011 Jan 31;173(5):346-9. Danish. PubMed
PMID: 21276398.


48: Vestergaard P, Mosekilde L. [Cohort study on effects of parathyroid surgery
in primary hyperparathyroidism]. Ugeskr Laeger. 2004 Aug 9;166(33):2807-10.
Danish. PubMed PMID: 15344862.


49: Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and
their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue
Int. 2009 Jan;84(1):45-55. doi: 10.1007/s00223-008-9195-5. Epub 2008 Dec 9.
PubMed PMID: 19067021.


50: Vestergaard P, Mosekilde L, Langdahl B. Fracture prevention in postmenopausal
women. BMJ Clin Evid. 2011 May 3;2011. pii: 1109. PubMed PMID: 21542947; PubMed
Central PMCID: PMC3217780.


51: Amstrup AK, Rejnmark L, Mosekilde L. Patients with surgically cured primary
hyperparathyroidism have a reduced quality of life compared with population-based
healthy sex-, age-, and season-matched controls. Eur J Endocrinol. 2011
Nov;165(5):753-60. doi: 10.1530/EJE-11-0301. Epub 2011 Aug 23. PubMed PMID:
21862666.


52: Rejnmark L, Vestergaard P, Mosekilde L. Are fractures due to anticoagulants
or the disease necessitating the treatment? Int J Cardiol. 2008 Jul
21;127(3):423-4. Epub 2007 Aug 8. PubMed PMID: 17689756.


53: Nissen PH, Christensen SE, Wallace A, Heickendorff L, Brixen K, Mosekilde L. 
Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy
number variation in the calcium sensing receptor gene: no large rearrangements
identified in patients with calcium metabolic disorders. Clin Endocrinol (Oxf).
2010 Jun;72(6):758-62. doi: 10.1111/j.1365-2265.2009.03750.x. Epub 2009 Nov 11.
PubMed PMID: 19912241.


54: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with
chronic lung diseases treated with bronchodilator drugs and inhaled and oral
corticosteroids. Chest. 2007 Nov;132(5):1599-607. Epub 2007 Sep 21. PubMed PMID: 
17890464.


55: Mosekilde L, Tørring O, Rejnmark L. Emerging anabolic treatments in
osteoporosis. Curr Drug Saf. 2011 Apr;6(2):62-74. Review. PubMed PMID: 21524248.


56: Vestergaard P, Rejnmark L, Mosekilde L. Loss of life years after a hip
fracture. Acta Orthop. 2009 Oct;80(5):525-30. doi: 10.3109/17453670903316835.
PubMed PMID: 19916683; PubMed Central PMCID: PMC2823336.


57: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with
different types of cancer. Acta Oncol. 2009;48(1):105-15. doi:
10.1080/02841860802167490. PubMed PMID: 18607871.


58: Vestergaard P, Rejnmark L, Mosekilde L. Fracture reducing potential of
hormone replacement therapy on a population level. Maturitas. 2006 Jun
20;54(3):285-93. Epub 2006 Jan 18. PubMed PMID: 16413706.


59: Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in users of oral
anticoagulants: a nationwide case-control study. Int J Cardiol. 2007 Jun
12;118(3):338-44. Epub 2006 Oct 18. PubMed PMID: 17055083.


60: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Postsurgical
hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract,
and infections. J Bone Miner Res. 2014 Nov;29(11):2504-10. doi:
10.1002/jbmr.2273. PubMed PMID: 24806578.


61: Vestergaard P, Mosekilde L. Fracture risk in patients with celiac Disease,
Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416
patients in Denmark. Am J Epidemiol. 2002 Jul 1;156(1):1-10. PubMed PMID:
12076883.


62: Vestergaard P, Mosekilde L. [Incidence of primary hyperparathyroidism,
frequency of surgical interventions and mortality based on the data from the
National Patient Registry]. Ugeskr Laeger. 2004 Jan 5;166(1-2):41-5. Danish.
PubMed PMID: 14752992.


63: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in very young women
using combined oral contraceptives. Contraception. 2008 Nov;78(5):358-64. doi:
10.1016/j.contraception.2008.06.010. Epub 2008 Aug 8. PubMed PMID: 18929731.


64: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Risk of
atrial fibrillation associated with use of bisphosphonates and other drugs
against osteoporosis: a cohort study. Calcif Tissue Int. 2010 May;86(5):335-42.
doi: 10.1007/s00223-010-9349-0. Epub 2010 Mar 23. PubMed PMID: 20309678.


65: Mosekilde L, Vestergaard P, Langdahl B. Fracture prevention in postmenopausal
women. Clin Evid. 2006 Jun;(15):1543-60. Review. PubMed PMID: 16973058.


66: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The Epidemiology of
Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study. J
Bone Miner Res. 2015 Sep;30(9):1738-44. doi: 10.1002/jbmr.2501. Epub 2015 May 31.
PubMed PMID: 25753591.


67: Vestergaard P, Fischer L, Mele M, Mosekilde L, Christiansen P. Use of
bisphosphonates and risk of breast cancer. Calcif Tissue Int. 2011
Apr;88(4):255-62. doi: 10.1007/s00223-011-9463-7. Epub 2011 Jan 21. PubMed PMID: 
21253712.


68: Moser E, Sikjaer T, Mosekilde L, Rejnmark L. Bone Indices in Thyroidectomized
Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and
HR-pQCT. J Thyroid Res. 2015;2015:796871. doi: 10.1155/2015/796871. Epub 2015 Jul
13. PubMed PMID: 26246934; PubMed Central PMCID: PMC4515520.




69: Nissen PH, Christensen SE, Heickendorff L, Brixen K, Mosekilde L. Molecular
genetic analysis of the calcium sensing receptor gene in patients clinically
suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and 
mutation spectrum in a Danish population. J Clin Endocrinol Metab. 2007
Nov;92(11):4373-9. Epub 2007 Aug 14. PubMed PMID: 17698911.


70: Vestergaard P, Nielsen LR, Mosekilde L. [Teriparatide (human recombinant 1-34
parathyroid hormone)--a new treatment regimen for severe osteoporosis]. Ugeskr
Laeger. 2004 Aug 2;166(32):2653-5. Review. Danish. PubMed PMID: 15347166.


71: Sikjaer T, Rejnmark L, Mosekilde L. PTH treatment in hypoparathyroidism. Curr
Drug Saf. 2011 Apr;6(2):89-99. Review. PubMed PMID: 21524246.


72: Sikjaer T, Amstrup AK, Rolighed L, Kjaer SG, Mosekilde L, Rejnmark L.
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled
trial on pharmacokinetic and dynamic effects after 6 months of treatment. J Bone 
Miner Res. 2013 Oct;28(10):2232-43. doi: 10.1002/jbmr.1964. PubMed PMID:
23649554.


73: Schwarz P, Jorgensen NR, Mosekilde L, Vestergaard P. Effects of increasing
age, dosage, and duration of PTH treatment on BMD increase--a meta-analysis.
Calcif Tissue Int. 2012 Mar;90(3):165-73. doi: 10.1007/s00223-011-9564-3. Epub
2012 Jan 13. Review. PubMed PMID: 22237954.


74: Nielsen LR, Vestergaard P, Mosekilde L. [Drugs with side effects affecting
calcium homeostasis, bone metabolism and risk of fractures]. Ugeskr Laeger. 2005 
Feb 28;167(9):1026-30. Review. Danish. PubMed PMID: 15803998.


75: Vestergaard P, Rejnmark L, Mosekilde L. Effect of tamoxifen and aromatase
inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue
Int. 2008 May;82(5):334-40. doi: 10.1007/s00223-008-9132-7. Epub 2008 May 8.
PubMed PMID: 18463912.


76: Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE
inhibitors, and calcium-channel blockers is associated with a reduced fracture
risk: a nationwide case-control study. J Hypertens. 2006 Mar;24(3):581-9. PubMed 
PMID: 16467662.


77: Harsløf T, Sikjær T, Sørensen L, Pedersen SB, Mosekilde L, Langdahl BL,
Rejnmark L. The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and
Energy Metabolism in Hypoparathyroidism. J Clin Endocrinol Metab. 2015
Jul;100(7):2758-62. doi: 10.1210/jc.2015-1477. Epub 2015 May 8. PubMed PMID:
25955226.


78: Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sørensen HT, Mosekilde L.
Hip fracture risk in statin users--a population-based Danish case-control study. 
Osteoporos Int. 2004 Jun;15(6):452-8. Epub 2004 Feb 17. PubMed PMID: 15205716.


79: Frost L, Vestergaard P, Mosekilde L. [Hyperthyroidism and risk of atrial
fibrillation or flutter--secondary publication. A population-based study]. Ugeskr
Laeger. 2005 Aug 29;167(35):3305-7. Danish. PubMed PMID: 16138975.


80: Vestergaard P, Kristensen K, Bruun JM, Østergaard JR, Heickendorff L,
Mosekilde L, Richelsen B. Reduced bone mineral density and increased bone
turnover in Prader-Willi syndrome compared with controls matched for sex and body
mass index--a cross-sectional study. J Pediatr. 2004 May;144(5):614-9. PubMed
PMID: 15126995.


81: Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal
calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011
Aug;96(8):2377-85. doi: 10.1210/jc.2011-0569. Epub 2011 Jun 6. Review. PubMed
PMID: 21646371.


82: Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial
fibrillation or flutter: a population-based study. Arch Intern Med. 2004 Aug
9-23;164(15):1675-8. Erratum in: Arch Intern Med. 2005 Feb 14;165(3):307. PubMed 
PMID: 15302638.


83: Nissen PH, Christensen SE, Ladefoged SA, Brixen K, Heickendorff L, Mosekilde 
L. Identification of rare and frequent variants of the CASR gene by
high-resolution melting. Clin Chim Acta. 2012 Mar 22;413(5-6):605-11. doi:
10.1016/j.cca.2011.12.004. Epub 2011 Dec 13. PubMed PMID: 22192860.


84: Schwarz P, Jorgensen NR, Mosekilde L, Vestergaard P. The evidence for
efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic
review and meta-analysis of antiresorptive and anabolic treatment in men. J
Osteoporos. 2011;2011:259818. doi: 10.4061/2011/259818. Epub 2011 Jun 24. PubMed 
PMID: 21776371; PubMed Central PMCID: PMC3138068.


85: Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, Salovaara
K, Cooper C, Smith HE, Jacobs ET, Torgerson D, Jackson RD, Manson JE, Brixen K,
Mosekilde L, Robbins JA, Francis RM, Abrahamsen B. Vitamin D with calcium reduces
mortality: patient level pooled analysis of 70,528 patients from eight major
vitamin D trials. J Clin Endocrinol Metab. 2012 Aug;97(8):2670-81. doi:
10.1210/jc.2011-3328. Epub 2012 May 17. PubMed PMID: 22605432; PubMed Central
PMCID: PMC3410276.


86: Jakobsen NF, Rolighed L, Moser E, Nissen PH, Mosekilde L, Rejnmark L.
Increased trabecular volumetric bone mass density in Familial Hypocalciuric
Hypercalcemia (FHH) type 1: a cross-sectional study. Calcif Tissue Int. 2014
Aug;95(2):141-52. doi: 10.1007/s00223-014-9877-0. Epub 2014 Jun 4. PubMed PMID:
24894639.


87: Vestergaard P, Lindholm J, Jørgensen JO, Hagen C, Hoeck HC, Laurberg P,
Rejnmark L, Brixen K, Kristensen LØ, Feldt-Rasmussen U, Mosekilde L. Increased
risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J
Endocrinol. 2002 Jan;146(1):51-6. PubMed PMID: 11751067.


88: Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L,
Christiansen JS. Marked disproportionality in bone size and mineral, and distinct
abnormalities in bone markers and calcitropic hormones in adult turner syndrome: 
a cross-sectional study. J Clin Endocrinol Metab. 2002 Jun;87(6):2798-808. PubMed
PMID: 12050253.


89: Gribsholt SB, Stochholm K, Mosekilde L, Vestergaard P. [Heterotopic
ossification in the brain can occur without preceding trauma]. Ugeskr Laeger.
2014 Jul 21;176(30):1411-2. Danish. PubMed PMID: 25292237.


90: Amstrup AK, Jakobsen NF, Moser E, Sikjaer T, Mosekilde L, Rejnmark L.
Association between bone indices assessed by DXA, HR-pQCT and QCT scans in
post-menopausal women. J Bone Miner Metab. 2015 Aug 21. [Epub ahead of print]
PubMed PMID: 26293682.


91: Vestergaard P, Rejnmark L, Mosekilde L. Oral contraceptive use and risk of
fractures. Contraception. 2006 Jun;73(6):571-6. Epub 2006 Mar 13. PubMed PMID:
16730486.


92: Mosekilde L, Nielsen LR, Larsen ER, Moosgaard B, Heickendorff L. [Vitamin D
deficiency. Definition and prevalence in Denmark]. Ugeskr Laeger. 2005 Jan
3;167(1):29-33. Review. Danish. PubMed PMID: 15675161.


93: Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM,
Mosekilde L, Prentice RL, Prince RL. Response to "calcium supplements increase
risk of myocardial infarction". J Bone Miner Res. 2015 Feb;30(2):391-2. doi:
10.1002/jbmr.2368. PubMed PMID: 25413937.


94: Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM,
Mosekilde L, Prentice RL, Prince RL. The effects of calcium supplementation on
verified coronary heart disease hospitalization and death in postmenopausal
women: a collaborative meta-analysis of randomized controlled trials. J Bone
Miner Res. 2015 Jan;30(1):165-75. doi: 10.1002/jbmr.2311. Review. PubMed PMID:
25042841.


95: Rolighed L, Amstrup AK, Jakobsen NF, Sikjaer T, Mosekilde L, Christiansen P, 
Rejnmark L. Muscle function is impaired in patients with "asymptomatic" primary
hyperparathyroidism. World J Surg. 2014 Mar;38(3):549-57. doi:
10.1007/s00268-013-2273-5. PubMed PMID: 24101026.


96: Starup-Linde J, Waldhauer E, Rolighed L, Mosekilde L, Vestergaard P. Renal
stones and calcifications in patients with primary hyperparathyroidism:
associations with biochemical variables. Eur J Endocrinol. 2012
Jun;166(6):1093-100. doi: 10.1530/EJE-12-0032. Epub 2012 Apr 3. PubMed PMID:
22474170.


97: Isaksen T, Nielsen CS, Christensen SE, Nissen PH, Heickendorff L, Mosekilde
L. Forearm bone mineral density in familial hypocalciuric hypercalcemia and
primary hyperparathyroidism: a comparative study. Calcif Tissue Int. 2011
Oct;89(4):285-94. doi: 10.1007/s00223-011-9517-x. Epub 2011 Jul 22. PubMed PMID: 
21785908.


98: Við Streym S, Rejnmark L, Mosekilde L, Vestergaard P. No effect of season of 
birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart
disease, while some variations may be seen for pneumonia and multiple sclerosis. 
Dermatoendocrinol. 2013 Apr 1;5(2):309-16. doi: 10.4161/derm.22779. PubMed PMID: 
24194971; PubMed Central PMCID: PMC3772919.


99: Vestergaard P, Mosekilde L. Fracture risk is decreased in acromegaly--a
potential beneficial effect of growth hormone. Osteoporos Int. 2004
Feb;15(2):155-9. Epub 2003 Nov 19. PubMed PMID: 14625668.


100: Rolighed L, Vestergaard P, Heickendorff L, Sikjaer T, Rejnmark L, Mosekilde 
L, Christiansen P. BMD improvements after operation for primary
hyperparathyroidism. Langenbecks Arch Surg. 2013 Jan;398(1):113-20. doi:
10.1007/s00423-012-1026-5. Epub 2012 Nov 7. PubMed PMID: 23132462.


101: Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L,
Køber L, Jensen JE. Vitamin D deficiency in postmenopausal, healthy women
predicts increased cardiovascular events: a 16-year follow-up study. Eur J
Endocrinol. 2012 Oct;167(4):553-60. doi: 10.1530/EJE-12-0283. Epub 2012 Aug 8.
PubMed PMID: 22875588.


102: Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Parathyroid response to
vitamin D insufficiency: relations to bone, body composition and to lifestyle
characteristics. Clin Endocrinol (Oxf). 2008 Jul;69(1):29-35. doi:
10.1111/j.1365-2265.2008.03186.x. Epub 2008 Jul 1. PubMed PMID: 18208576.




103: Vestergaard P, Emborg C, Støving RK, Hagen C, Mosekilde L, Brixen K.
Patients with eating disorders. A high-risk group for fractures. Orthop Nurs.
2003 Sep-Oct;22(5):325-31. Review. PubMed PMID: 14595992.


104: Cleemann L, Hjerrild BE, Lauridsen AL, Heickendorff L, Christiansen JS,
Mosekilde L, Gravholt CH. Long-term hormone replacement therapy preserves bone
mineral density in Turner syndrome. Eur J Endocrinol. 2009 Aug;161(2):251-7. doi:
10.1530/EJE-09-0020. Epub 2009 May 15. PubMed PMID: 19447901.


105: Christensen SE, Nissen PH, Vestergaard P, Mosekilde L. Familial
hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes. 2011 
Dec;18(6):359-70. doi: 10.1097/MED.0b013e32834c3c7c. Review. PubMed PMID:
21986511.


106: Vestergaard P, Rejnmark L, Mosekilde L. Osteoporosis is markedly
underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2005
Feb;16(2):134-41. Epub 2004 Jun 12. PubMed PMID: 15197546.


107: Frost L, Vestergaard P, Mosekilde L, Mortensen LS. Trends in incidence and
mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark,
1980-1999. Int J Cardiol. 2005 Aug 3;103(1):78-84. PubMed PMID: 15922465.


108: Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L,
Køber L, Jensen JE. Effect of hormone replacement therapy on cardiovascular
events in recently postmenopausal women: randomised trial. BMJ. 2012 Oct
9;345:e6409. doi: 10.1136/bmj.e6409. PubMed PMID: 23048011.


109: Sikjaer T, Rejnmark L, Thomsen JS, Tietze A, Brüel A, Andersen G, Mosekilde 
L. Changes in 3-dimensional bone structure indices in hypoparathyroid patients
treated with PTH(1-84): a randomized controlled study. J Bone Miner Res. 2012
Apr;27(4):781-8. doi: 10.1002/jbmr.1493. PubMed PMID: 22161686.


110: Vestergaard P, Mosekilde L. Fractures in patients with primary
hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg.
2003 Mar;27(3):343-9. Epub 2003 Feb 27. PubMed PMID: 12607064.


111: Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L.
Current evidence for recommendation of surgery, medical treatment and vitamin D
repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011
Dec;165(6):851-64. doi: 10.1530/EJE-11-0589. Epub 2011 Sep 29. Review. PubMed
PMID: 21964961.


112: Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sørensen OH, Eiken P,
Nielsen SP, Mosekilde L. Effects of 5 years of hormonal replacement therapy on
menopausal symptoms and blood pressure-a randomised controlled study. Maturitas. 
2003 Oct 20;46(2):123-32. PubMed PMID: 14559383.




113: Vestergaard P, Emborg C, Støving RK, Hagen C, Mosekilde L, Brixen K.
Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating
disorders--a nationwide register study. Int J Eat Disord. 2002 Nov;32(3):301-8.
PubMed PMID: 12210644.


114: Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Jüppner
H, D'Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R,
Collins MT, Sliney J, Sanders J. Hypoparathyroidism in the adult: epidemiology,
diagnosis, pathophysiology, target-organ involvement, treatment, and challenges
for future research. J Bone Miner Res. 2011 Oct;26(10):2317-37. doi:
10.1002/jbmr.483. PubMed PMID: 21812031; PubMed Central PMCID: PMC3405491.


115: Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M,
Mosekilde L. Cardiovascular events before and after surgery for primary
hyperparathyroidism. World J Surg. 2003 Feb;27(2):216-22. PubMed PMID: 12616440.


116: Abrahamsen B, Vestergaard P, Rud B, Bärenholdt O, Jensen JE, Nielsen SP,
Mosekilde L, Brixen K. Ten-year absolute risk of osteoporotic fractures according
to BMD T score at menopause: the Danish Osteoporosis Prevention Study. J Bone
Miner Res. 2006 May;21(5):796-800. PubMed PMID: 16734396.




117: Jensen MB, Houborg KB, Vestergaard P, Kissmeyer-Nielsen P, Mosekilde L,
Laurberg S. Improved physical performance and increased lean tissue and fat mass 
in patients with ulcerative colitis four to six years after ileoanal anastomosis 
with a J-pouch. Dis Colon Rectum. 2002 Dec;45(12):1601-7. PubMed PMID: 12473882.


118: Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P,
Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before
and after parathyroid surgery: controlled retrospective follow up study. BMJ.
2002 Oct 12;325(7368):807. PubMed PMID: 12376441; PubMed Central PMCID:
PMC128947.


119: Lauridsen AL, Vestergaard P, Hermann AP, Moller HJ, Mosekilde L, Nexo E.
Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner 
Res. 2004 Jun;19(6):875-81. Epub 2004 Jan 27. PubMed PMID: 15125786.


120: Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery
on multiple outcomes in primary hyperparathyroidism. BMJ. 2003 Sep
6;327(7414):530-4. PubMed PMID: 12958111; PubMed Central PMCID: PMC192894.


121: Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for
fractures. Calcif Tissue Int. 2009 Feb;84(2):103-11. doi:
10.1007/s00223-008-9198-2. Epub 2008 Dec 5. PubMed PMID: 19067019.


122: Jakobsen NF, Rolighed L, Nissen PH, Mosekilde L, Rejnmark L. Muscle function
and quality of life are not impaired in familial hypocalciuric hypercalcemia: a
cross-sectional study on physiological effects of inactivating variants in the
calcium-sensing receptor gene (CASR). Eur J Endocrinol. 2013 Aug
28;169(3):349-57. doi: 10.1530/EJE-13-0224. Print 2013 Sep. PubMed PMID:
23764372.


123: Rejnmark L, Vestergaard P, Kassem M, Christoffersen BR, Kolthoff N, Brixen
K, Mosekilde L. Fracture risk in perimenopausal women treated with beta-blockers.
Calcif Tissue Int. 2004 Nov;75(5):365-72. Epub 2004 Aug 12. PubMed PMID:
15592792.


124: Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop
diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal
women: results from a randomized controlled study with bumetanide. J Bone Miner
Res. 2006 Jan;21(1):163-70. Epub 2005 Oct 10. PubMed PMID: 16355285.


125: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with
different types of oral corticosteroids and effect of termination of
corticosteroids on the risk of fractures. Calcif Tissue Int. 2008
Apr;82(4):249-57. doi: 10.1007/s00223-008-9124-7. Epub 2008 Apr 15. PubMed PMID: 
18414920.


126: Vestergaard P, Rejnmark L, Mosekilde L. Osteoarthritis and risk of
fractures. Calcif Tissue Int. 2009 Apr;84(4):249-56. doi:
10.1007/s00223-009-9224-z. Epub 2009 Feb 23. PubMed PMID: 19234808.


127: Vestergaard P, Rejnmark L, Mosekilde L. Selective serotonin reuptake
inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int.
2008 Feb;82(2):92-101. doi: 10.1007/s00223-007-9099-9. Epub 2008 Jan 25. PubMed
PMID: 18219438.


128: Vestergaard P, Rejnmark L, Mosekilde L. Socioeconomic aspects of fractures
within universal public healthcare: a nationwide case-control study from Denmark.
Scand J Public Health. 2006;34(4):371-7. PubMed PMID: 16861187.


129: Ueland T, Bollerslev J, Mosekilde L. [Osteoclast function is regulated by
neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a
unique regulatory system for bone resorption with important pathophysiological
and therapeutic aspects]. Ugeskr Laeger. 2002 Jul 1;164(27):3526-30. Review.
Danish. PubMed PMID: 12116680.


130: Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, 
Mosekilde L. Effects of simvastatin on bone turnover and BMD: a 1-year randomized
controlled trial in postmenopausal osteopenic women. J Bone Miner Res. 2004
May;19(5):737-44. Epub 2004 Feb 16. PubMed PMID: 15068496.


131: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of
antiepileptic drugs. Epilepsia. 2004 Nov;45(11):1330-7. PubMed PMID: 15509233.


132: Vestergaard P, Jørgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L,
Brixen K, Weeke J, Andersen M, Conceicao FL, Nielsen TL, Mosekilde L. Fracture
risk is increased in patients with GH deficiency or untreated prolactinomas--a
case-control study. Clin Endocrinol (Oxf). 2002 Feb;56(2):159-67. PubMed PMID:
11874406.


133: Mosekilde L, Vestergaard P, Langdahl B. Fracture prevention in
postmenopausal women. Am Fam Physician. 2008 May 15;77(10):1447-8. PubMed PMID:
18533379.


134: Mosekilde L, Nielsen LR, Vestergaard P. [Strontium ranelate: a new
therapeutic principle for postmenopausal osteoporosis]. Ugeskr Laeger. 2005 Sep
12;167(37):3485-7. Danish. PubMed PMID: 16159455.


135: Mosekilde L, Vestergaard P, Langdahl B. Fracture prevention in
postmenopausal women. BMJ Clin Evid. 2007 Sep 1;2007. pii: 1109. PubMed PMID:
19450301.


136: Vestergaard P, Mosekilde L, Brixen K. [Treatment of osteoporosis with
antiresorptive drugs]. Ugeskr Laeger. 2005 Feb 21;167(8):883-7. Review. Danish.
PubMed PMID: 15789840.




137: Vestergaard P, Nielsen LR, Mosekilde L. [Cinacalcet--a new drug for the
treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid 
cancer or primary hyperparathyroidism]. Ugeskr Laeger. 2006 Jan 3;168(1):29-32.
Review. Danish. PubMed PMID: 16393559.


138: Vestergaard P, Rejnmark L, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Laurberg
P, Mosekilde L. Smoking as a risk factor for Graves' disease, toxic nodular
goiter, and autoimmune hypothyroidism. Thyroid. 2002 Jan;12(1):69-75. PubMed
PMID: 11838733.


139: Gravholt CH, Hjerrild BE, Mosekilde L, Hansen TK, Rasmussen LM, Frystyk J,
Flyvbjerg A, Christiansen JS. Body composition is distinctly altered in Turner
syndrome: relations to glucose metabolism, circulating adipokines, and
endothelial adhesion molecules. Eur J Endocrinol. 2006 Oct;155(4):583-92. PubMed 
PMID: 16990658.


140: Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen 
JS. Increased fracture rates in Turner's syndrome: a nationwide questionnaire
survey. Clin Endocrinol (Oxf). 2003 Jul;59(1):89-96. PubMed PMID: 12807509.


141: Bollerslev J, Marks SC Jr, Mosekilde L, Lian JB, Stein GS, Mosekilde L.
Cortical bone osteocalcin content and matrix composition in autosomal dominant
osteopetrosis type I. Eur J Endocrinol. 1994 Jun;130(6):592-4. PubMed PMID:
8205260.


142: Brixen KT, Abrahamsen B, Kassem MS, Mosekilde L. [Pharmacological treatment 
of osteitis deformans (Paget's bone disease)]. Ugeskr Laeger. 2005 Feb
28;167(9):1009-12. Review. Danish. PubMed PMID: 15803994.


143: Brixen K, Schwarz P, Mosekilde L. [Improved intervention against vitamin D
deficiency and osteoporosis required]. Ugeskr Laeger. 2005 Feb 21;167(8):867.
Danish. PubMed PMID: 15789835.


144: Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen PM,
Blichert-Toft M. [Renal stone and primary hyperparathyroidism. Risk of renal
stone before and after parathyroidectomy]. Ugeskr Laeger. 2004 Oct
11;166(42):3726-8. Danish. PubMed PMID: 15508296.


145: Jacobsen AT, Mosekilde L. [Vitamin D deficiency in ethnic minorities].
Ugeskr Laeger. 2005 Jan 3;167(1):33-4. Danish. PubMed PMID: 15675162.


146: Mosekilde L, Brot C, Hyldstrup L, Mortensen LS, Mølgård C, Rasmussen SE,
Mejborn H, Rasmussen LB; Arbejdsgruppe nedsat af Danmarks Fødevareforskning. [The
vitamin D status of the Danish population needs to be improved]. Ugeskr Laeger.
2005 Feb 21;167(8):895-7. Danish. PubMed PMID: 15789843.


147: Nielsen LR, Mosekilde L. [Vitamin D and breast cancer]. Ugeskr Laeger. 2007 
Apr 2;169(14):1299-302. Review. Danish. PubMed PMID: 17437690.


148: Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005
Mar;62(3):265-81. Review. PubMed PMID: 15730407.


149: Mosekilde L. Primary hyperparathyroidism and the skeleton. Clin Endocrinol
(Oxf). 2008 Jul;69(1):1-19. doi: 10.1111/j.1365-2265.2007.03162.x. Epub 2008 Jul 
1. Review. PubMed PMID: 18167138.


150: Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation
of asymptomatic primary hyperparathyroidism: proceedings of the third
international workshop. J Clin Endocrinol Metab. 2009 Feb;94(2):351-65. doi:
10.1210/jc.2008-1760. Review. PubMed PMID: 19193910.


151: Kassem M, Mosekilde L, Rungby J, Mosekilde L, Melsen F, Eriksen EF.
Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow
cultures. APMIS. 1991 Mar;99(3):262-8. PubMed PMID: 2018639.


152: Abrahamsen B, Rejnmark L, Nielsen SP, Rud B, Nissen N, Mosekilde L,
Bärenholdt O, Jensen JE. Ten-year prediction of osteoporosis from baseline bone
mineral density: development of prognostic thresholds in healthy postmenopausal
women. The Danish Osteoporosis Prevention Study. Osteoporos Int. 2006
Feb;17(2):245-51. Epub 2005 Sep 10. PubMed PMID: 16155732.


153: Abrahamsen B, Tofteng CL, Bärenholdt O, Vestergaard P, Stilgren LS,
Beck-Nielsen H, Nielsen SP, Sørensen OH, Mosekilde L; Danish Osteoporosis
Prevention Study. Standardization of BMD T-Scores in the first five years after
the menopause: do femoral neck-equivalent and older normative range T-Scores
improve diagnostic agreement? J Clin Densitom. 2003 Summer;6(2):87-95. PubMed
PMID: 12794230.


154: Mosekilde L, Mosekilde L, Danielsen CC. Biomechanical competence of
vertebral trabecular bone in relation to ash density and age in normal
individuals. Bone. 1987;8(2):79-85. PubMed PMID: 3593611.


155: Schwarz P, Brixen KT, Mosekilde L. [Calcium homeostasis and normal bone
remodeling]. Ugeskr Laeger. 2005 Feb 21;167(8):871-3. Review. Danish. PubMed
PMID: 15789837.




156: Nielsen HE, Mosekilde L, Mosekilde L, Melsen B, Christensen P, Olsen KJ,
Melsen F. Relations of bone mineral content, ash weight and bone mass:
implication for correction of bone mineral content for bone size. Clin Orthop
Relat Res. 1980 Nov-Dec;(153):241-7. PubMed PMID: 7449223.


157: Mosekilde L. Vitamin D requirement and setting recommendation levels:
long-term perspectives. Nutr Rev. 2008 Oct;66(10 Suppl 2):S170-7. doi:
10.1111/j.1753-4887.2008.00103.x. Review. PubMed PMID: 18844845.


158: Jensen KS, Mosekilde L, Mosekilde L. A model of vertebral trabecular bone
architecture and its mechanical properties. Bone. 1990;11(6):417-23. PubMed PMID:
2078435.


159: Bollerslev J, Mosekilde L, Nielsen HK, Mosekilde L. Biomechanical competence
of iliac crest trabecular bone in autosomal dominant osteopetrosis type I. Bone. 
1989;10(3):159-64. PubMed PMID: 2803852.


160: Nørholt SE, Bjerregaard J, Mosekilde L. Maxillary distraction osteogenesis
in a patient with pycnodysostosis: a case report. J Oral Maxillofac Surg. 2004
Aug;62(8):1037-40. PubMed PMID: 15278873.


161: Gravholt CH, Hjerrild BE, Naeraa RW, Engbaek F, Mosekilde L, Christiansen
JS. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and
body composition in girls with Turner syndrome. Clin Endocrinol (Oxf). 2005
May;62(5):616-22. PubMed PMID: 15853835.




162: Rolighed L, Bollerslev J, Mosekilde L. Vitamin D treatment in primary
hyperparathyroidism. Curr Drug Saf. 2011 Apr;6(2):100-7. Review. PubMed PMID:
21524245.




163: Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L,
Wamberg L, Orskov L. Effects of 12 weeks high dose vitamin D3 treatment on
insulin sensitivity, beta cell function, and metabolic markers in patients with
type 2 diabetes and vitamin D insufficiency - a double-blind, randomized,
placebo-controlled trial. Metabolism. 2014 Sep;63(9):1115-24. doi:
10.1016/j.metabol.2014.06.008. Epub 2014 Jun 19. PubMed PMID: 25044176.


164: Hosking DJ, O'Brien M, Brandi ML, Minne HW, Mosekilde L, Ringe J, Suppan G, 
Walsh JB. Declaration on Vitamin D in Osteoporosis Management: From the European 
Summit on the Role of Vitamin D in the Management of Osteoporosis: a MetaForum.
Clin Cases Miner Bone Metab. 2007 May;4(2):163-6. PubMed PMID: 22461218; PubMed
Central PMCID: PMC2781241.


165: Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation
prevents severe falls in elderly community-dwelling women: a pragmatic
population-based 3-year intervention study. Aging Clin Exp Res. 2005
Apr;17(2):125-32. PubMed PMID: 15977461.


166: Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation
prevents osteoporotic fractures in elderly community dwelling residents: a
pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004
Mar;19(3):370-8. Epub 2003 Dec 22. PubMed PMID: 15040824.


167: Larsen ER, Mosekilde L, Foldspang A. Determinants of acceptance of a
community-based program for the prevention of falls and fractures among the
elderly. Prev Med. 2001 Aug;33(2 Pt 1):115-9. PubMed PMID: 11493044.


168: Larsen ER, Mosekilde L, Foldspang A. Correlates of falling during 24 h among
elderly Danish community residents. Prev Med. 2004 Aug;39(2):389-98. PubMed PMID:
15226051.


169: Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen
SR, Brixen K, Mosekilde L. A common methylenetetrahydrofolate reductase (C677T)
polymorphism is associated with low bone mineral density and increased fracture
incidence after menopause: longitudinal data from the Danish osteoporosis
prevention study. J Bone Miner Res. 2003 Apr;18(4):723-9. PubMed PMID: 12674333.


170: Brixen KT, Mosekilde L. [Alendronate once a week]. Ugeskr Laeger. 2003 Jun
30;165(27):2734-9. Danish. PubMed PMID: 12886563.


171: Brixen KT, Illum NO, Hansen B, Lund AM, Mosekilde L. [Oesteogenesis
imperfecta--genetics, diagnosis and medical treatment]. Ugeskr Laeger. 2007 Jan
1;169(1):30-4. Review. Danish. PubMed PMID: 17217883.


172: van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K,
Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson
C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, 
Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge
S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellström D,
Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, 
Weber K, Ioannidis JP, Uitterlinden AG; GENOMOS Study. Large-scale analysis of
association between LRP5 and LRP6 variants and osteoporosis. JAMA. 2008 Mar
19;299(11):1277-90. doi: 10.1001/jama.299.11.1277. PubMed PMID: 18349089; PubMed 
Central PMCID: PMC3282142.


173: Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB,
Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey
AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, McGuigan FE,
Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE, Uitterlinden AG; GENOMOS
Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis
outcomes. JAMA. 2004 Nov 3;292(17):2105-14. PubMed PMID: 15523071.


174: Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO,
Christiansen JS. Short-term growth hormone treatment in girls with Turner
syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, 
placebo-controlled, crossover study. Pediatrics. 2002 Nov;110(5):889-96. PubMed
PMID: 12415026.


175: Langdahl BL, Uitterlinden AG, Ralston SH, Trikalinos TA, Balcells S, Brandi 
ML, Scollen S, Lips P, Lorenc R, Obermayer-Pietsch B, Reid DM, Armas JB, Arp PP, 
Bassiti A, Bustamante M, Husted LB, Carey AH, Pérez Cano R, Dobnig H, Dunning AM,
Fahrleitner-Pammer A, Falchetti A, Karczmarewicz E, Kruk M, van Leeuwen JP, Masi 
L, van Meurs JB, Mangion J, McGuigan FE, Mellibovsky L, Mosekilde L, Nogués X,
Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Ioannidis JP; APOSS
investigators; DOPS investigators; EPOS investigators; EPOLOS investigators;
FAMOS investigators; LASA investigators; ERGO investigators; GENOMOS Study.
Large-scale analysis of association between polymorphisms in the transforming
growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone. 2008
May;42(5):969-81. doi: 10.1016/j.bone.2007.11.007. Epub 2007 Dec 3. PubMed PMID: 
18284942.


176: Søgaard CH, Mosekilde L, Richards A, Mosekilde L. Marked decrease in
trabecular bone quality after five years of sodium fluoride therapy--assessed by 
biomechanical testing of iliac crest bone biopsies in osteoporotic patients.
Bone. 1994 Jul-Aug;15(4):393-9. PubMed PMID: 7917577.


177: Søgaard CH, Hermann AP, Hasling C, Mosekilde L, Mosekilde L. Spine deformity
index in osteoporotic women: relations to forearm and vertebral bone mineral
measurements and to iliac crest ash density. Osteoporos Int. 1994 Jul;4(4):211-9.
PubMed PMID: 7949751.


178: Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P,
Laurberg P, Frystyk J, Flyvbjerg A, Christiansen JS, Gravholt CH. The metabolic
syndrome is frequent in Klinefelter's syndrome and is associated with abdominal
obesity and hypogonadism. Diabetes Care. 2006 Jul;29(7):1591-8. PubMed PMID:
16801584.


179: Mosekilde L, Mosekilde L. Sex differences in age-related changes in
vertebral body size, density and biomechanical competence in normal individuals. 
Bone. 1990;11(2):67-73. PubMed PMID: 2357425.


180: Steiniche T, Christiansen P, Vesterby A, Ullerup R, Hessov I, Mosekilde LE, 
Melsen F. Primary hyperparathyroidism: bone structure, balance, and remodeling
before and 3 years after surgical treatment. Bone. 2000 May;26(5):535-43. PubMed 
PMID: 10773596.


181: Ortoft G, Mosekilde L, Hasling C, Mosekilde L. Estimation of vertebral body 
strength by dual photon absorptiometry in elderly individuals: comparison between
measurements of total vertebral and vertebral body bone mineral. Bone. 1993
Jul-Aug;14(4):667-73. PubMed PMID: 8274311.


182: Danielsen CC, Mosekilde L, Bollerslev J, Mosekilde L. Thermal stability of
cortical bone collagen in relation to age in normal individuals and in
individuals with osteopetrosis. Bone. 1994 Jan-Feb;15(1):91-6. PubMed PMID:
8024858.


183: Mosekilde L, Moosgaard B, Jensen JE, Nielsen LR. [Non-skeletal effects of
vitamin D deficiency]. Ugeskr Laeger. 2005 Feb 21;167(8):887-91. Review. Danish. 
PubMed PMID: 15789841.


184: Amstrup AK, Jakobsen NF, Lomholt S, Sikjaer T, Mosekilde L, Rejnmark L.
Inverse Correlation at the Hip Between Areal Bone Mineral Density Measured by
Dual-Energy X-ray Absorptiometry and Cortical Volumetric Bone Mineral Density
Measured by Quantitative Computed Tomography. J Clin Densitom. 2015 Feb 17. pii: 
S1094-6950(15)00003-7. doi: 10.1016/j.jocd.2015.01.002. [Epub ahead of print]
PubMed PMID: 25700661.


185: Vesterby A, Mosekilde L, Gundersen HJ, Melsen F, Mosekilde L, Holme K,
Sørensen S. Biologically meaningful determinants of the in vitro strength of
lumbar vertebrae. Bone. 1991;12(3):219-24. PubMed PMID: 1910963.


186: Søgaard CH, Mosekilde L, Richards A, Mosekilde L. [Loss of trabecular bone
strength and bone quality after 5 years of fluoride therapy for osteoporosis].
Ugeskr Laeger. 1995 Apr 3;157(14):2004-8. Danish. PubMed PMID: 7740640.


187: Ueland T, Brixen K, Mosekilde L, Mosekilde L, Flyvbjerg A, Bollerslev J.
Age-related changes in cortical bone content of insulin-like growth factor
binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in
postmenopausal osteoporosis: a cross-sectional study. J Clin Endocrinol Metab.
2003 Mar;88(3):1014-8. PubMed PMID: 12629078.


188: Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen
SR, Brixen K, Mosekilde L. Are effects of MTHFR (C677T) genotype on BMD confined 
to women with low folate and riboflavin intake? Analysis of food records from the
Danish osteoporosis prevention study. Bone. 2005 Mar;36(3):577-83. PubMed PMID:
15777680.


189: Mosekilde L, Mosekilde L. Normal vertebral body size and compressive
strength: relations to age and to vertebral and iliac trabecular bone compressive
strength. Bone. 1986;7(3):207-12. PubMed PMID: 3768199.


190: Mosekilde L. [Is osteoporosis treatment cost-efficient?]. Ugeskr Laeger.
2002 Mar 4;164(10):1329. Danish. PubMed PMID: 11894422.


191: Mosekilde L, Mosekilde L. Iliac crest trabecular bone volume as predictor
for vertebral compressive strength, ash density and trabecular bone volume in
normal individuals. Bone. 1988;9(4):195-9. PubMed PMID: 3166835.




192: Mosekilde L, Viidik A, Mosekilde L. Correlation between the compressive
strength of iliac and vertebral trabecular bone in normal individuals. Bone.
1985;6(5):291-5. PubMed PMID: 4096861.


193: Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos 
P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP. Efficacy
and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism 
(REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet 
Diabetes Endocrinol. 2013 Dec;1(4):275-83. doi: 10.1016/S2213-8587(13)70106-2.
Epub 2013 Oct 7. Erratum in: Lancet Diabetes Endocrinol. 2014 Jan;2(1):e3. Dosage
error in article text. PubMed PMID: 24622413.




194: Tfelt-Hansen J, Brixen KT, Mosekilde L, Schwarz P. [Parathyroid
hormone-related peptide induced humoral hypercalcemia of malignancy]. Ugeskr
Laeger. 2005 Feb 21;167(8):924-6. Danish. PubMed PMID: 15789851.


195: Hansen KW, Mosekilde L. [Gitelman syndrome. An overlooked disease with
chronic hypomagnesemia and hypokalemia in adults]. Ugeskr Laeger. 2003 Mar
10;165(11):1123-7. Review. Danish. PubMed PMID: 12677988.


196: Mosekilde L, Pallisgaard G. [Alveolitis fibrosa: an exogenically determined 
syndrome?]. Ugeskr Laeger. 1978 Sep 11;140(37):2239-43. Danish. PubMed PMID:
684949.


197: Mosekilde L, Hansen HJ. [Cryptococcosis. A case of pulmonary and
meningocerebral cryptococcosis treated with amphotericin and lobectomy]. Ugeskr
Laeger. 1974 Dec 30;137(1):34-6. Danish. PubMed PMID: 4480323.


198: Mosekilde L, Strunge P. [Yersinia eneterocolitica arthritis and
myocarditits]. Ugeskr Laeger. 1978 Jun 19;140(25):1482-3. Danish. PubMed PMID:
684885.


199: Lomholt S, Amstrup AK, Moser E, Jakobsen NF, Mosekilde L, Vestergaard P,
Rejnmark L. Unexplained high BMD in DXA-scanned patients is generalized
throughout the skeleton and characterized by thicker cortical and trabecular
bone. Calcif Tissue Int. 2015 Apr;96(4):284-94. doi: 10.1007/s00223-015-9955-y.
Epub 2015 Jan 23. PubMed PMID: 25609586.


200: Sikjaer T, Rolighed L, Hess A, Fuglsang-Frederiksen A, Mosekilde L, Rejnmark
L. Effects of PTH(1-84) therapy on muscle function and quality of life in
hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int.
2014 Jun;25(6):1717-26. doi: 10.1007/s00198-014-2677-6. Epub 2014 Apr 1. PubMed
PMID: 24687385.
 
201: Við Streym S, Kristine Moller U, Rejnmark L, Heickendorff L, Mosekilde L,
Vestergaard P. Maternal and infant vitamin D status during the first 9 months of 
infant life-a cohort study. Eur J Clin Nutr. 2013 Oct;67(10):1022-8. doi:
10.1038/ejcn.2013.152. Epub 2013 Sep 4. PubMed PMID: 24002039.


202: Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. Melatonin and the skeleton. 
Osteoporos Int. 2013 Dec;24(12):2919-27. doi: 10.1007/s00198-013-2404-8. Epub
2013 May 29. Review. PubMed PMID: 23716040.


203: Harsløf T, Frost M, Nielsen TL, Husted LB, Nyegaard M, Brixen K, Børglum AD,
Mosekilde L, Andersen M, Rejnmark L, Langdahl BL. Polymorphisms of muscle genes
are associated with bone mass and incident osteoporotic fractures in Caucasians. 
Calcif Tissue Int. 2013 May;92(5):467-76. doi: 10.1007/s00223-013-9702-1. Epub
2013 Feb 1. PubMed PMID: 23370486.


204: Rejnmark L, Sikjaer T, Underbjerg L, Mosekilde L. PTH replacement therapy of
hypoparathyroidism. Osteoporos Int. 2013 May;24(5):1529-36. doi:
10.1007/s00198-012-2230-4. Epub 2012 Nov 27. Review. PubMed PMID: 23184178.


205: Møller UK, Streym S, Mosekilde L, Heickendorff L, Flyvbjerg A, Frystyk J,
Jensen LT, Rejnmark L. Changes in calcitropic hormones, bone markers and
insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a
controlled cohort study. Osteoporos Int. 2013 Apr;24(4):1307-20. doi:
10.1007/s00198-012-2062-2. Epub 2012 Aug 2. PubMed PMID: 22855199.


206: Møller UK, Streym S, Heickendorff L, Mosekilde L, Rejnmark L. Effects of
25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort
study in healthy Danish women. Eur J Clin Nutr. 2012 Jul;66(7):862-8. doi:
10.1038/ejcn.2012.18. Epub 2012 Feb 29. PubMed PMID: 22378226.


207: Vestergaard P, Hermann P, Jensen JE, Eiken P, Mosekilde L. Effects of
paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and
opioids on bone mineral density and risk of fracture: results of the Danish
Osteoporosis Prevention Study (DOPS). Osteoporos Int. 2012 Apr;23(4):1255-65.
doi: 10.1007/s00198-011-1692-0. Epub 2011 Jun 28. PubMed PMID: 21710339.


208: Møller UK, Við Streym S, Mosekilde L, Rejnmark L. Changes in bone mineral
density and body composition during pregnancy and postpartum. A controlled cohort
study. Osteoporos Int. 2012 Apr;23(4):1213-23. doi: 10.1007/s00198-011-1654-6.
Epub 2011 May 25. PubMed PMID: 21607805.


209: Vestergaard P, Schwartz F, Rejnmark L, Mosekilde L. Risk of femoral shaft
and subtrochanteric fractures among users of bisphosphonates and raloxifene.
Osteoporos Int. 2011 Mar;22(3):993-1001. doi: 10.1007/s00198-010-1512-y. Epub
2010 Dec 17. PubMed PMID: 21165600.


210: Harsløf T, Husted LB, Nyegaard M, Carstens M, Stenkjær L, Brixen K, Eiken P,
Jensen JE, Børglum AD, Mosekilde L, Rejnmark L, Langdahl BL. Polymorphisms in the
ALOX12 gene and osteoporosis. Osteoporos Int. 2011 Aug;22(8):2249-59. doi:
10.1007/s00198-010-1472-2. Epub 2010 Nov 23. PubMed PMID: 21104233.


211: Harsløf T, Tofteng CL, Husted LB, Nyegaard M, Børglum A, Carstens M,
Stenkjær L, Brixen K, Eiken P, Jensen JE, Mosekilde L, Rejnmark L, Langdahl BL.
Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene
are associated with osteoporosis. Osteoporos Int. 2011 Oct;22(10):2655-66. doi:
10.1007/s00198-010-1491-z. Epub 2010 Nov 23. PubMed PMID: 21104228.


212: Bojesen A, Birkebæk N, Kristensen K, Heickendorff L, Mosekilde L,
Christiansen JS, Gravholt CH. Bone mineral density in Klinefelter syndrome is
reduced and primarily determined by muscle strength and resorptive markers, but
not directly by testosterone. Osteoporos Int. 2011 May;22(5):1441-50. doi:
10.1007/s00198-010-1354-7. Epub 2010 Jul 24. PubMed PMID: 20658127.


213: Vestergaard P, Rejnmark L, Mosekilde L. Risk of fractures associated with
treatment for benign prostate hyperplasia in men. Osteoporos Int. 2011
Feb;22(2):731-7. doi: 10.1007/s00198-010-1320-4. Epub 2010 Jun 15. PubMed PMID:
20552327.


214: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Stroke in
relation to use of raloxifene and other drugs against osteoporosis. Osteoporos
Int. 2011 Apr;22(4):1037-45. doi: 10.1007/s00198-010-1276-4. Epub 2010 May 7.
PubMed PMID: 20449570.


215: Jones L, Thomsen JS, Barlach J, Mosekilde L, Melsen B. No influence of
alimentary zinc on the healing of calvarial defects filled with osteopromotive
substances in rats. Eur J Orthod. 2010 Apr;32(2):124-30. doi: 10.1093/ejo/cjp076.
Epub 2010 Jan 11. PubMed PMID: 20064837.


216: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Use of
bisphosphonates and raloxifene and risk of deep venous thromboembolism and
pulmonary embolism. Osteoporos Int. 2010 Sep;21(9):1591-7. doi:
10.1007/s00198-009-1091-y. Epub 2009 Oct 27. PubMed PMID: 19859641.


217: Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS,
Rubin MR, Goltzman D, Silverberg SJ, Marx SJ, Peacock M, Mosekilde L, Bouillon R,
Lewiecki EM. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings
of the third international workshop. J Clin Endocrinol Metab. 2009
Feb;94(2):340-50. doi: 10.1210/jc.2008-1758. Review. PubMed PMID: 19193909.


218: Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L,
Vestergaard P. Global vitamin D levels in relation to age, gender, skin
pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 
2009 Jan;20(1):133-40. doi: 10.1007/s00198-008-0626-y. Epub 2008 May 6. PubMed
PMID: 18458986.


219: Rejnmark L, Vestergaard P, Hermann AP, Brot C, Eiken P, Mosekilde L. Dietary
intake of folate, but not vitamin B2 or B12, is associated with increased bone
mineral density 5 years after the menopause: results from a 10-year follow-up
study in early postmenopausal women. Calcif Tissue Int. 2008 Jan;82(1):1-11. doi:
10.1007/s00223-007-9087-0. Epub 2008 Jan 4. PubMed PMID: 18175033.


220: Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, 
Mosekilde L. Vitamin D metabolites and skeletal consequences in primary
hyperparathyroidism. Clin Endocrinol (Oxf). 2008 May;68(5):707-15. Epub 2007 Nov 
2. PubMed PMID: 17980013.


221: Jones L, Thomsen JS, Mosekilde L, Bosch C, Melsen B. Biomechanical
evaluation of rat skull defects, 1, 3, and 6 months after implantation with
osteopromotive substances. J Craniomaxillofac Surg. 2007 Dec;35(8):350-7. Epub
2007 Oct 24. PubMed PMID: 17951064.


222: Vestergaard P, Jorgensen NR, Schwarz P, Mosekilde L. Effects of treatment
with fluoride on bone mineral density and fracture risk--a meta-analysis.
Osteoporos Int. 2008 Mar;19(3):257-68. Epub 2007 Aug 15. Review. PubMed PMID:
17701094.


223: Nissen N, Gravholt CH, Abrahamsen B, Hauge EM, Jensen JE, Mosekilde L,
Brixen K. Disproportional geometry of the proximal femur in patients with Turner 
syndrome: a cross-sectional study. Clin Endocrinol (Oxf). 2007 Dec;67(6):897-903.
Epub 2007 Aug 6. PubMed PMID: 17681028.


224: Vestergaard P, Rejnmark L, Mosekilde L. Increased mortality in patients with
a hip fracture-effect of pre-morbid conditions and post-fracture complications.
Osteoporos Int. 2007 Dec;18(12):1583-93. Epub 2007 Jun 14. PubMed PMID: 17566814.


225: Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L. Plasma
1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body
mass index, plasma phosphate and renal function. Clin Endocrinol (Oxf). 2007
Jan;66(1):35-42. PubMed PMID: 17201799.


226: Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated
with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control
study. Osteoporos Int. 2007 Apr;18(4):409-17. Epub 2006 Nov 9. PubMed PMID:
17093893.


227: Rasmussen K, Larsen LP, Arveschoug A, Theil Nielsen J, Vestergaard P,
Rønning H, Mosekilde L, Christiansen P. Predictive value of parathyroid
scintigraphy in the preoperative evaluation of patients with primary
hyperparathyroidism. Scand J Surg. 2006;95(3):199-204. PubMed PMID: 17066618.


228: Vestergaard P, Jorgensen NR, Mosekilde L, Schwarz P. Effects of parathyroid 
hormone alone or in combination with antiresorptive therapy on bone mineral
density and fracture risk--a meta-analysis. Osteoporos Int. 2007 Jan;18(1):45-57.
Epub 2006 Sep 2. Review. PubMed PMID: 16951908.


229: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of
nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and
the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int. 2006
Aug;79(2):84-94. Epub 2006 Aug 15. PubMed PMID: 16927048.


230: Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2
receptor antagonists, and other antacid medications and the risk of fracture.
Calcif Tissue Int. 2006 Aug;79(2):76-83. Epub 2006 Aug 15. PubMed PMID: 16927047.


231: Vestergaard P, Rejnmark L, Mosekilde L. Methotrexate, azathioprine,
cyclosporine, and risk of fracture. Calcif Tissue Int. 2006 Aug;79(2):69-75. Epub
2006 Aug 15. PubMed PMID: 16927044.


232: Rejnmark L, Vestergaard P, Mosekilde L. Statin but not non-statin
lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Calcif Tissue Int. 2006 Jul;79(1):27-36. Epub 2006 Jul 24. PubMed PMID: 16868664.


233: Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P,
Mosekilde L. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is
associated with parathyroid adenoma secretion in primary hyperparathyroidism: a
cross-sectional study. Eur J Endocrinol. 2006 Aug;155(2):237-44. PubMed PMID:
16868136.


234: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the
use of morphine and opiates. J Intern Med. 2006 Jul;260(1):76-87. PubMed PMID:
16789982.


235: Møller UK, Ramlau-Hansen CH, Rejnmark L, Heickendorff L, Henriksen TB,
Mosekilde L. Postpartum vitamin D insufficiency and secondary hyperparathyroidism
in healthy Danish women. Eur J Clin Nutr. 2006 Oct;60(10):1214-21. Epub 2006 May 
24. PubMed PMID: 16721399.


236: Rejnmark L, Lauridsen AL, Brot C, Vestergaard P, Heickendorff L, Nexo E,
Mosekilde L. Vitamin D and its binding protein Gc: long-term variability in peri-
and postmenopausal women with and without hormone replacement therapy. Scand J
Clin Lab Invest. 2006;66(3):227-38. PubMed PMID: 16714251.


237: Rejnmark L, Vestergaard P, Cha
yle="color: rgb(0, 0, 0); line-height: normal;">1: Við Streym S, Højskov CS, Møller UK, Heickendorff L, Vestergaard P, Mosekilde L, Rejnmark L. Vitamin D content in human breast milk: a 9-mo follow-up study. Am J Clin Nutr. 2016 Jan;103(1):107-14. doi: 10.3945/ajcn.115.115105. Epub 2015 Dec 16. PubMed PMID: 26675779. 2: Greibe E, Lildballe DL, Streym S, Vestergaard P, Rejnmark L, Mosekilde L, Nexo E. Cobalamin and haptocorrin in human milk and cobalamin-related variables in mother and child: a 9-mo longitudinal study. Am J Clin Nutr. 2013 Aug;98(2):389-95. doi: 10.3945/ajcn.113.058479. PubMed PMID: 23783295. 3: Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, Mosekilde L. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2655-60. doi: 10.1158/1055-9965.EPI-09-0531. Epub 2009 Sep 29. PubMed PMID: 19789365. 4: Møller UK, Jensen LT, Mosekilde L, Rejnmark L. Effects of adding chymosin to milk on calcium homeostasis: a randomized, double-blind, cross-over study. Calcif Tissue Int. 2015 Feb;96(2):105-12. doi: 10.1007/s00223-014-9942-8. Epub 2014 Dec 18. PubMed PMID: 25515208. 5: Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, Christiansen P. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab. 2014 Mar;99(3):1072-80. doi: 10.1210/jc.2013-3978. Epub 2014 Jan 13. PubMed PMID: 24423366. 6: Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr J. 2015 Sep 30;14:102. doi: 10.1186/s12937-015-0093-1. PubMed PMID: 26424587; PubMed Central PMCID: PMC4590707. 7: Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol (Oxf). 2011 Jan;74(1):37-43. doi: 10.1111/j.1365-2265.2010.03894.x. PubMed PMID: 21039730. 8: Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf). 2008 Nov;69(5):713-20. doi: 10.1111/j.1365-2265.2008.03259.x. Epub 2008 Apr 10. PubMed PMID: 18410554. 9: Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, Christiansen P. No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial. Eur J Endocrinol. 2015 May;172(5):609-17. doi: 10.1530/EJE-14-0940. Epub 2015 Feb 2. PubMed PMID: 25646406. 10: Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002 May;12(5):411-9. PubMed PMID: 12097203. 11: Gissel T, Rejnmark L, Mosekilde L, Vestergaard P. Intake of vitamin D and risk of breast cancer--a meta-analysis. J Steroid Biochem Mol Biol. 2008 Sep;111(3-5):195-9. doi: 10.1016/j.jsbmb.2008.06.002. Epub 2008 Jun 11. PubMed PMID: 18590821. 12: Andersen S, Laurberg P, Hvingel B, Kleinschmidt K, Heickendorff L, Mosekilde L. Vitamin D status in Greenland is influenced by diet and ethnicity: a population-based survey in an Arctic society in transition. Br J Nutr. 2013 Mar 14;109(5):928-35. doi: 10.1017/S0007114512002097. Epub 2012 Jun 8. PubMed PMID: 22682501. 13: Møller UK, Streym Sv, Jensen LT, Mosekilde L, Schoenmakers I, Nigdikar S, Rejnmark L. Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients. 2013 Sep 5;5(9):3470-80. doi: 10.3390/nu5093470. PubMed PMID: 24013463; PubMed Central PMCID: PMC3798915. 14: Amstrup AK, Sikjaer T, Pedersen SB, Heickendorff L, Mosekilde L, Rejnmark L. Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial. Clin Endocrinol (Oxf). 2015 Sep 9. doi: 10.1111/cen.12942. [Epub ahead of print] PubMed PMID: 26352863. 15: Vestergaard P, Rejnmark L, Mosekilde L. High-dose treatment with vitamin A analogues and risk of fractures. Arch Dermatol. 2010 May;146(5):478-82. doi: 10.1001/archdermatol.2010.59. PubMed PMID: 20479294. 16: Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol. 2010;2010:957174. doi: 10.1155/2010/957174. Epub 2009 Jul 21. PubMed PMID: 20016680; PubMed Central PMCID: PMC2778175. 17: Rejnmark L, Vestergaard P, Mosekilde L. Pre-existing diseases and use of loop diuretics may explain increased mortality in secondary hyperparathyroidism. Clin Endocrinol (Oxf). 2008 Sep;69(3):514. doi: 10.1111/j.1365-2265.2008.03223.x. Epub 2008 Feb 13. PubMed PMID: 18284642. 18: Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis D. Eur J Endocrinol. 2008 Apr;158(4):571-6. doi: 10.1530/EJE-07-0844. PubMed PMID: 18362305. 19: Vestergaard P, Støen OG, Swenson JE, Mosekilde L, Heickendorff L, Fröbert O. Vitamin D status and bone and connective tissue turnover in brown bears (Ursus arctos) during hibernation and the active state. PLoS One. 2011;6(6):e21483. doi: 10.1371/journal.pone.0021483. Epub 2011 Jun 23. PubMed PMID: 21731765; PubMed Central PMCID: PMC3121767. 20: Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism. Clin Endocrinol (Oxf). 2009 Dec;71(6):798-807. doi: 10.1111/j.1365-2265.2009.03557.x. Epub 2009 Feb 25. PubMed PMID: 19250271. 21: Mosekilde L, Vestergaard P, Rejnmark L. The pathogenesis, treatment and prevention of osteoporosis in men. Drugs. 2013 Jan;73(1):15-29. doi: 10.1007/s40265-012-0003-1. Review. PubMed PMID: 23329464. 22: Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics and sedatives and risk of fractures: effects of half-life. Calcif Tissue Int. 2008 Jan;82(1):34-43. doi: 10.1007/s00223-007-9095-0. Epub 2008 Jan 4. PubMed PMID: 18175030. 23: Rejnmark L, Lauridsen AL, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. Eur J Endocrinol. 2002 May;146(5):635-42. PubMed PMID: 11980618. 24: Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study. Calcif Tissue Int. 2011 Mar;88(3):238-45. doi: 10.1007/s00223-010-9454-0. Epub 2010 Dec 23. PubMed PMID: 21181400. 25: Vestergaard P, Rejnmark L, Mosekilde L. Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int. 2011 Mar;88(3):209-14. doi: 10.1007/s00223-010-9450-4. Epub 2010 Dec 16. PubMed PMID: 21161194. 26: Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study. J Clin Endocrinol Metab. 2013 Jan;98(1):87-96. doi: 10.1210/jc.2012-2499. Epub 2012 Nov 12. PubMed PMID: 23150677. 27: Rejnmark L, Vestergaard P, Mosekilde L. Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res. 2006 Nov;21(11):1811-7. PubMed PMID: 17054422. 28: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Pseudohypoparathyroidism - epidemiology, mortality and risk of complications. Clin Endocrinol (Oxf). 2015 Sep 21. doi: 10.1111/cen.12948. [Epub ahead of print] PubMed PMID: 26387561. 29: Vestergaard P, Rejnmark L, Mosekilde L. Has mortality after a hip fracture increased? J Am Geriatr Soc. 2007 Nov;55(11):1720-6. Epub 2007 Oct 3. PubMed PMID: 17916118. 30: Vestergaard P, Mosekilde L. [No effect of calcium supplementation on bone mineral density in children. Survey of a Cochrane review]. Ugeskr Laeger. 2007 Jun 25;169(26):2512-5. Review. Danish. PubMed PMID: 17725895. 31: Rejnmark L, Mosekilde L. New and emerging antiresorptive treatments in osteoporosis. Curr Drug Saf. 2011 Apr;6(2):75-88. Review. PubMed PMID: 21524247. 32: Vestergaard P, Rejnmark L, Mosekilde L. The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception. 2008 Dec;78(6):459-64. doi: 10.1016/j.contraception.2008.07.014. Epub 2008 Sep 10. PubMed PMID: 19014791. 33: Vestergaard P, Rejnmark L, Mosekilde L. [Osteoporosis and fractures associated with drugs]. Ugeskr Laeger. 2008 Apr 28;170(18):1550-5. Review. Danish. PubMed PMID: 18454925. 34: Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L. Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res. 2015 Sep;59(2):221-9. doi: 10.1111/jpi.12252. Epub 2015 Jun 24. PubMed PMID: 26036434. 35: Vestergaard P, Rejnmark L, Mosekilde L. [Strongly increasing incidence of hip fractures in Denmark from 1977 to 1999]. Ugeskr Laeger. 2008 Feb 18;170(8):621-3. Danish. PubMed PMID: 18367043. 36: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int. 2007 Sep;81(3):153-61. Epub 2007 Aug 20. PubMed PMID: 17705047. 37: Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L; Hypoparathyroid Study Group. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res. 2011 Oct;26(10):2358-70. doi: 10.1002/jbmr.470. PubMed PMID: 21773992. 38: Vestergaard P, Mosekilde L. [Medical treatment of patients with primary hyperparathyroidism]. Ugeskr Laeger. 2009 Aug 10;171(33):2284-7. Danish. PubMed PMID: 19732508. 39: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Gastric and esophagus events before and during treatment of osteoporosis. Calcif Tissue Int. 2010 Feb;86(2):110-5. doi: 10.1007/s00223-009-9323-x. Epub 2009 Dec 3. PubMed PMID: 19957165. 40: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013 Nov;28(11):2277-85. doi: 10.1002/jbmr.1979. PubMed PMID: 23661265. 41: Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol. 2008 Dec;159(6):719-27. doi: 10.1530/EJE-08-0440. Epub 2008 Sep 11. PubMed PMID: 18787045. 42: Amstrup AK, Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Effects of smoking on severity of disease in primary hyperparathyroidism. Calcif Tissue Int. 2010 Nov;87(5):406-13. doi: 10.1007/s00223-010-9416-6. Epub 2010 Sep 23. PubMed PMID: 20862465. 43: Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. Thyroid. 2003 Jun;13(6):585-93. Review. PubMed PMID: 12930603. 44: Amstrup AK, Rejnmark L, Vestergaard P, Sikjaer T, Rolighed L, Heickendorff L, Mosekilde L. Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study. Clin Endocrinol (Oxf). 2011 Jan;74(1):130-6. doi: 10.1111/j.1365-2265.2010.03906.x. PubMed PMID: 21044111. 45: Vestergaard P, Schwartz K, Rejnmark L, Mosekilde L, Pinholt EM. Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. J Oral Maxillofac Surg. 2012 Apr;70(4):821-9. doi: 10.1016/j.joms.2011.02.093. Epub 2011 Jul 20. PubMed PMID: 21764202. 46: Mosekilde L, Langdahl BL, Nielsen LR, Vestergaard P. [The usefulness of calcium and vitamin D supplementation after the Women's Health Initiative trial]. Ugeskr Laeger. 2007 Sep 24;169(39):3273-6. Review. Danish. PubMed PMID: 17953883. 47: Rejnmark L, Vestergaard P, Mosekilde L. [Denosumab--a new efficient osteoporosis therapy]. Ugeskr Laeger. 2011 Jan 31;173(5):346-9. Danish. PubMed PMID: 21276398. 48: Vestergaard P, Mosekilde L. [Cohort study on effects of parathyroid surgery in primary hyperparathyroidism]. Ugeskr Laeger. 2004 Aug 9;166(33):2807-10. Danish. PubMed PMID: 15344862. 49: Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2009 Jan;84(1):45-55. doi: 10.1007/s00223-008-9195-5. Epub 2008 Dec 9. PubMed PMID: 19067021. 50: Vestergaard P, Mosekilde L, Langdahl B. Fracture prevention in postmenopausal women. BMJ Clin Evid. 2011 May 3;2011. pii: 1109. PubMed PMID: 21542947; PubMed Central PMCID: PMC3217780. 51: Amstrup AK, Rejnmark L, Mosekilde L. Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. Eur J Endocrinol. 2011 Nov;165(5):753-60. doi: 10.1530/EJE-11-0301. Epub 2011 Aug 23. PubMed PMID: 21862666. 52: Rejnmark L, Vestergaard P, Mosekilde L. Are fractures due to anticoagulants or the disease necessitating the treatment? Int J Cardiol. 2008 Jul 21;127(3):423-4. Epub 2007 Aug 8. PubMed PMID: 17689756. 53: Nissen PH, Christensen SE, Wallace A, Heickendorff L, Brixen K, Mosekilde L. Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disorders. Clin Endocrinol (Oxf). 2010 Jun;72(6):758-62. doi: 10.1111/j.1365-2265.2009.03750.x. Epub 2009 Nov 11. PubMed PMID: 19912241. 54: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest. 2007 Nov;132(5):1599-607. Epub 2007 Sep 21. PubMed PMID: 17890464. 55: Mosekilde L, Tørring O, Rejnmark L. Emerging anabolic treatments in osteoporosis. Curr Drug Saf. 2011 Apr;6(2):62-74. Review. PubMed PMID: 21524248. 56: Vestergaard P, Rejnmark L, Mosekilde L. Loss of life years after a hip fracture. Acta Orthop. 2009 Oct;80(5):525-30. doi: 10.3109/17453670903316835. PubMed PMID: 19916683; PubMed Central PMCID: PMC2823336. 57: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in patients with different types of cancer. Acta Oncol. 2009;48(1):105-15. doi: 10.1080/02841860802167490. PubMed PMID: 18607871. 58: Vestergaard P, Rejnmark L, Mosekilde L. Fracture reducing potential of hormone replacement therapy on a population level. Maturitas. 2006 Jun 20;54(3):285-93. Epub 2006 Jan 18. PubMed PMID: 16413706. 59: Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol. 2007 Jun 12;118(3):338-44. Epub 2006 Oct 18. PubMed PMID: 17055083. 60: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014 Nov;29(11):2504-10. doi: 10.1002/jbmr.2273. PubMed PMID: 24806578. 61: Vestergaard P, Mosekilde L. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol. 2002 Jul 1;156(1):1-10. PubMed PMID: 12076883. 62: Vestergaard P, Mosekilde L. [Incidence of primary hyperparathyroidism, frequency of surgical interventions and mortality based on the data from the National Patient Registry]. Ugeskr Laeger. 2004 Jan 5;166(1-2):41-5. Danish. PubMed PMID: 14752992. 63: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk in very young women using combined oral contraceptives. Contraception. 2008 Nov;78(5):358-64. doi: 10.1016/j.contraception.2008.06.010. Epub 2008 Aug 8. PubMed PMID: 18929731. 64: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study. Calcif Tissue Int. 2010 May;86(5):335-42. doi: 10.1007/s00223-010-9349-0. Epub 2010 Mar 23. PubMed PMID: 20309678. 65: Mosekilde L, Vestergaard P, Langdahl B. Fracture prevention in postmenopausal women. Clin Evid. 2006 Jun;(15):1543-60. Review. PubMed PMID: 16973058. 66: Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study. J Bone Miner Res. 2015 Sep;30(9):1738-44. doi: 10.1002/jbmr.2501. Epub 2015 May 31. PubMed PMID: 25753591. 67: Vestergaard P, Fischer L, Mele M, Mosekilde L, Christiansen P. Use of bisphosphonates and risk of breast cancer. Calcif Tissue Int. 2011 Apr;88(4):255-62. doi: 10.1007/s00223-011-9463-7. Epub 2011 Jan 21. PubMed PMID: 21253712. 68: Moser E, Sikjaer T, Mosekilde L, Rejnmark L. Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT. J Thyroid Res. 2015;2015:796871. doi: 10.1155/2015/796871. Epub 2015 Jul 13. PubMed PMID: 26246934; PubMed Central PMCID: PMC4515520. 69: Nissen PH, Christensen SE, Heickendorff L, Brixen K, Mosekilde L. Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab. 2007 Nov;92(11):4373-9. Epub 2007 Aug 14. PubMed PMID: 17698911. 70: Vestergaard P, Nielsen LR, Mosekilde L. [Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis]. Ugeskr Laeger. 2004 Aug 2;166(32):2653-5. Review. Danish. PubMed PMID: 15347166. 71: Sikjaer T, Rejnmark L, Mosekilde L. PTH treatment in hypoparathyroidism. Curr Drug Saf. 2011 Apr;6(2):89-99. Review. PubMed PMID: 21524246. 72: Sikjaer T, Amstrup AK, Rolighed L, Kjaer SG, Mosekilde L, Rejnmark L. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. J Bone Miner Res. 2013 Oct;28(10):2232-43. doi: 10.1002/jbmr.1964. PubMed PMID: 23649554. 73: Schwarz P, Jorgensen NR, Mosekilde L, Vestergaard P. Effects of increasing age, dosage, and duration of PTH treatment on BMD increase--a meta-analysis. Calcif Tissue Int. 2012 Mar;90(3):165-73. doi: 10.1007/s00223-011-9564-3. Epub 2012 Jan 13. Review. PubMed PMID: 22237954. 74: Nielsen LR, Vestergaard P, Mosekilde L. [Drugs with side effects affecting calcium homeostasis, bone metabolism and risk of fractures]. Ugeskr Laeger. 2005 Feb 28;167(9):1026-30. Review. Danish. PubMed PMID: 15803998. 75: Vestergaard P, Rejnmark L, Mosekilde L. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue Int. 2008 May;82(5):334-40. doi: 10.1007/s00223-008-9132-7. Epub 2008 May 8. PubMed PMID: 18463912. 76: Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens. 2006 Mar;24(3):581-9. PubMed PMID: 16467662. 77: Harsløf T, Sikjær T, Sørensen L, Pedersen SB, Mosekilde L, Langdahl BL, Rejnmark L. The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and Energy Metabolism in Hypoparathyroidism. J Clin Endocrinol Metab. 2015 Jul;100(7):2758-62. doi: 10.1210/jc.2015-1477. Epub 2015 May 8. PubMed PMID: 25955226. 78: Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sørensen HT, Mosekilde L. Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int. 2004 Jun;15(6):452-8. Epub 2004 Feb 17. PubMed PMID: 15205716. 79: Frost L, Vestergaard P, Mosekilde L. [Hyperthyroidism and risk of atrial fibrillation or flutter--secondary publication. A population-based study]. Ugeskr Laeger. 2005 Aug 29;167(35):3305-7. Danish. PubMed PMID: 16138975. 80: Vestergaard P, Kristensen K, Bruun JM, Østergaard JR, Heickendorff L, Mosekilde L, Richelsen B. Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study. J Pediatr. 2004 May;144(5):614-9. PubMed PMID: 15126995. 81: Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011 Aug;96(8):2377-85. doi: 10.1210/jc.2011-0569. Epub 2011 Jun 6. Review. PubMed PMID: 21646371. 82: Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004 Aug 9-23;164(15):1675-8. Erratum in: Arch Intern Med. 2005 Feb 14;165(3):307. PubMed PMID: 15302638. 83: Nissen PH, Christensen SE, Ladefoged SA, Brixen K, Heickendorff L, Mosekilde L. Identification of rare and frequent variants of the CASR gene by high-resolution melting. Clin Chim Acta. 2012 Mar 22;413(5-6):605-11. doi: 10.1016/j.cca.2011.12.004. Epub 2011 Dec 13. PubMed PMID: 22192860. 84: Schwarz P, Jorgensen NR, Mosekilde L, Vestergaard P. The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men. J Osteoporos. 2011;2011:259818. doi: 10.4061/2011/259818. Epub 2011 Jun 24. PubMed PMID: 21776371; PubMed Central PMCID: PMC3138068. 85: Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, Salovaara K, Cooper C, Smith HE, Jacobs ET, Torgerson D, Jackson RD, Manson JE, Brixen K, Mosekilde L, Robbins JA, Francis RM, Abrahamsen B. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab. 2012 Aug;97(8):2670-81. doi: 10.1210/jc.2011-3328. Epub 2012 May 17. PubMed PMID: 22605432; PubMed Central PMCID: PMC3410276. 86: Jakobsen NF, Rolighed L, Moser E, Nissen PH, Mosekilde L, Rejnmark L. Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional study. Calcif Tissue Int. 2014 Aug;95(2):141-52. doi: 10.1007/s00223-014-9877-0. Epub 2014 Jun 4. PubMed PMID: 24894639. 87: Vestergaard P, Lindholm J, Jørgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LØ, Feldt-Rasmussen U, Mosekilde L. Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol. 2002 Jan;146(1):51-6. PubMed PMID: 11751067. 88: Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. J Clin Endocrinol Metab. 2002 Jun;87(6):2798-808. PubMed PMID: 12050253. 89: Gribsholt SB, Stochholm K, Mosekilde L, Vestergaard P. [Heterotopic ossification in the brain can occur without preceding trauma]. Ugeskr Laeger. 2014 Jul 21;176(30):1411-2. Danish. PubMed PMID: 25292237. 90: Amstrup AK, Jakobsen NF, Moser E, Sikjaer T, Mosekilde L, Rejnmark L. Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women. J Bone Miner Metab. 2015 Aug 21. [Epub ahead of print] PubMed PMID: 26293682. 91: Vestergaard P, Rejnmark L, Mosekilde L. Oral contraceptive use and risk of fractures. Contraception. 2006 Jun;73(6):571-6. Epub 2006 Mar 13. PubMed PMID: 16730486. 92: Mosekilde L, Nielsen LR, Larsen ER, Moosgaard B, Heickendorff L. [Vitamin D deficiency. Definition and prevalence in Denmark]. Ugeskr Laeger. 2005 Jan 3;167(1):29-33. Review. Danish. PubMed PMID: 15675161. 93: Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM, Mosekilde L, Prentice RL, Prince RL. Response to "calcium supplements increase risk of myocardial infarction". J Bone Miner Res. 2015 Feb;30(2):391-2. doi: 10.1002/jbmr.2368. PubMed PMID: 25413937. 94: Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM, Mosekilde L, Prentice RL, Prince RL. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res. 2015 Jan;30(1):165-75. doi: 10.1002/jbmr.2311. Review. PubMed PMID: 25042841. 95: Rolighed L, Amstrup AK, Jakobsen NF, Sikjaer T, Mosekilde L, Christiansen P, Rejnmark L. Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidism. World J Surg. 2014 Mar;38(3):549-57. doi: 10.1007/s00268-013-2273-5. PubMed PMID: 24101026. 96: Starup-Linde J, Waldhauer E, Rolighed L, Mosekilde L, Vestergaard P. Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables. Eur J Endocrinol. 2012 Jun;166(6):1093-100. doi: 10.1530/EJE-12-0032. Epub 2012 Apr 3. PubMed PMID: 22474170. 97: Isaksen T, Nielsen CS, Christensen SE, Nissen PH, Heickendorff L, Mosekilde L. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcif Tissue Int. 2011 Oct;89(4):285-94. doi: 10.1007/s00223-011-9517-x. Epub 2011 Jul 22. PubMed PMID: 21785908. 98: Við Streym S, Rejnmark L, Mosekilde L, Vestergaard P. No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis. Dermatoendocrinol. 2013 Apr 1;5(2):309-16. doi: 10.4161/derm.22779. PubMed PMID: 24194971; PubMed Central PMCID: PMC3772919. 99: Vestergaard P, Mosekilde L. Fracture risk is decreased in acromegaly--a potential beneficial effect of growth hormone. Osteoporos Int. 2004 Feb;15(2):155-9. Epub 2003 Nov 19. PubMed PMID: 14625668. 100: Rolighed L, Vestergaard P, Heickendorff L, Sikjaer T, Rejnmark L, Mosekilde L, Christiansen P. BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch Surg. 2013 Jan;398(1):113-20. doi: 10.1007/s00423-012-1026-5. Epub 2012 Nov 7. PubMed PMID: 23132462. 101: Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, Køber L, Jensen JE. Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study. Eur J Endocrinol. 2012 Oct;167(4):553-60. doi: 10.1530/EJE-12-0283. Epub 2012 Aug 8. PubMed PMID: 22875588. 102: Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics. Clin Endocrinol (Oxf). 2008 Jul;69(1):29-35. doi: 10.1111/j.1365-2265.2008.03186.x. Epub 2008 Jul 1. PubMed PMID: 18208576. 103: Vestergaard P, Emborg C, Støving RK, Hagen C, Mosekilde L, Brixen K. Patients with eating disorders. A high-risk group for fractures. Orthop Nurs. 2003 Sep-Oct;22(5):325-31. Review. PubMed PMID: 14595992. 104: Cleemann L, Hjerrild BE, Lauridsen AL, Heickendorff L, Christiansen JS, Mosekilde L, Gravholt CH. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur J Endocrinol. 2009 Aug;161(2):251-7. doi: 10.1530/EJE-09-0020. Epub 2009 May 15. PubMed PMID: 19447901. 105: Christensen SE, Nissen PH, Vestergaard P, Mosekilde L. Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):359-70. doi: 10.1097/MED.0b013e32834c3c7c. Review. PubMed PMID: 21986511. 106: Vestergaard P, Rejnmark L, Mosekilde L. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2005 Feb;16(2):134-41. Epub 2004 Jun 12. PubMed PMID: 15197546. 107: Frost L, Vestergaard P, Mosekilde L, Mortensen LS. Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol. 2005 Aug 3;103(1):78-84. PubMed PMID: 15922465. 108: Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, Køber L, Jensen JE. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012 Oct 9;345:e6409. doi: 10.1136/bmj.e6409. PubMed PMID: 23048011. 109: Sikjaer T, Rejnmark L, Thomsen JS, Tietze A, Brüel A, Andersen G, Mosekilde L. Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res. 2012 Apr;27(4):781-8. doi: 10.1002/jbmr.1493. PubMed PMID: 22161686. 110: Vestergaard P, Mosekilde L. Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg. 2003 Mar;27(3):343-9. Epub 2003 Feb 27. PubMed PMID: 12607064. 111: Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011 Dec;165(6):851-64. doi: 10.1530/EJE-11-0589. Epub 2011 Sep 29. Review. PubMed PMID: 21964961. 112: Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sørensen OH, Eiken P, Nielsen SP, Mosekilde L. Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study. Maturitas. 2003 Oct 20;46(2):123-32. PubMed PMID: 14559383. 113: Vestergaard P, Emborg C, Støving RK, Hagen C, Mosekilde L, Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study. Int J Eat Disord. 2002 Nov;32(3):301-8. PubMed PMID: 12210644. 114: Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Jüppner H, D'Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011 Oct;26(10):2317-37. doi: 10.1002/jbmr.483. PubMed PMID: 21812031; PubMed Central PMCID: PMC3405491. 115: Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg. 2003 Feb;27(2):216-22. PubMed PMID: 12616440. 116: Abrahamsen B, Vestergaard P, Rud B, Bärenholdt O, Jensen JE, Nielsen SP, Mosekilde L, Brixen K. Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study. J Bone Miner Res. 2006 May;21(5):796-800. PubMed PMID: 16734396. 117: Jensen MB, Houborg KB, Vestergaard P, Kissmeyer-Nielsen P, Mosekilde L, Laurberg S. Improved physical performance and increased lean tissue and fat mass in patients with ulcerative colitis four to six years after ileoanal anastomosis with a J-pouch. Dis Colon Rectum. 2002 Dec;45(12):1601-7. PubMed PMID: 12473882. 118: Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ. 2002 Oct 12;325(7368):807. PubMed PMID: 12376441; PubMed Central PMCID: PMC128947. 119: Lauridsen AL, Vestergaard P, Hermann AP, Moller HJ, Mosekilde L, Nexo E. Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner Res. 2004 Jun;19(6):875-81. Epub 2004 Jan 27. PubMed PMID: 15125786. 120: Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ. 2003 Sep 6;327(7414):530-4. PubMed PMID: 12958111; PubMed Central PMCID: PMC192894. 121: Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int. 2009 Feb;84(2):103-11. doi: 10.1007/s00223-008-9198-2. Epub 2008 Dec 5. PubMed PMID: 19067019. 122: Jakobsen NF, Rolighed L, Nissen PH, Mosekilde L, Rejnmark L. Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR). Eur J Endocrinol. 2013 Aug 28;169(3):349-57. doi: 10.1530/EJE-13-0224. Print 2013 Sep. PubMed PMID: 23764372. 123: Rejnmark L, Vestergaard P, Kassem M, Christoffersen BR, Kolthoff N, Brixen K, Mosekilde L. Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int. 2004 Nov;75(5):365-72. Epub 2004 Aug 12. PubMed PMID: 15592792. 124: Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res. 2006 Jan;21(1):163-70. Epub 2005 Oct 10. PubMed PMID: 16355285. 125: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int. 2008 Apr;82(4):249-57. doi: 10.1007/s00223-008-9124-7. Epub 2008 Apr 15. PubMed PMID: 18414920. 126: Vestergaard P, Rejnmark L, Mosekilde L. Osteoarthritis and risk of fractures. Calcif Tissue Int. 2009 Apr;84(4):249-56. doi: 10.1007/s00223-009-9224-z. Epub 2009 Feb 23. PubMed PMID: 19234808. 127: Vestergaard P, Rejnmark L, Mosekilde L. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int. 2008 Feb;82(2):92-101. doi: 10.1007/s00223-007-9099-9. Epub 2008 Jan 25. PubMed PMID: 18219438. 128: Vestergaard P, Rejnmark L, Mosekilde L. Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark. Scand J Public Health. 2006;34(4):371-7. PubMed PMID: 16861187. 129: Ueland T, Bollerslev J, Mosekilde L. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects]. Ugeskr Laeger. 2002 Jul 1;164(27):3526-30. Review. Danish. PubMed PMID: 12116680. 130: Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res. 2004 May;19(5):737-44. Epub 2004 Feb 16. PubMed PMID: 15068496. 131: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004 Nov;45(11):1330-7. PubMed PMID: 15509233. 132: Vestergaard P, Jørgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Weeke J, Andersen M, Conceicao FL, Nielsen TL, Mosekilde L. Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study. Clin Endocrinol (Oxf). 2002 Feb;56(2):159-67. PubMed PMID: 11874406. 133: Mosekilde L, Vestergaard P, Langdahl B. Fracture prevention in postmenopausal women. Am Fam Physician. 2008 May 15;77(10):1447-8. PubMed PMID: 18533379. 134: Mosekilde L, Nielsen LR, Vestergaard P. [Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis]. Ugeskr Laeger. 2005 Sep 12;167(37):3485-7. Danish. PubMed PMID: 16159455. 135: Mosekilde L, Vestergaard P, Langdahl B. Fracture prevention in postmenopausal women. BMJ Clin Evid. 2007 Sep 1;2007. pii: 1109. PubMed PMID: 19450301. 136: Vestergaard P, Mosekilde L, Brixen K. [Treatment of osteoporosis with antiresorptive drugs]. Ugeskr Laeger. 2005 Feb 21;167(8):883-7. Review. Danish. PubMed PMID: 15789840. 137: Vestergaard P, Nielsen LR, Mosekilde L. [Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism]. Ugeskr Laeger. 2006 Jan 3;168(1):29-32. Review. Danish. PubMed PMID: 16393559. 138: Vestergaard P, Rejnmark L, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Laurberg P, Mosekilde L. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid. 2002 Jan;12(1):69-75. PubMed PMID: 11838733. 139: Gravholt CH, Hjerrild BE, Mosekilde L, Hansen TK, Rasmussen LM, Frystyk J, Flyvbjerg A, Christiansen JS. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol. 2006 Oct;155(4):583-92. PubMed PMID: 16990658. 140: Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf). 2003 Jul;59(1):89-96. PubMed PMID: 12807509. 141: Bollerslev J, Marks SC Jr, Mosekilde L, Lian JB, Stein GS, Mosekilde L. Cortical bone osteocalcin content and matrix composition in autosomal dominant osteopetrosis type I. Eur J Endocrinol. 1994 Jun;130(6):592-4. PubMed PMID: 8205260. 142: Brixen KT, Abrahamsen B, Kassem MS, Mosekilde L. [Pharmacological treatment of osteitis deformans (Paget's bone disease)]. Ugeskr Laeger. 2005 Feb 28;167(9):1009-12. Review. Danish. PubMed PMID: 15803994. 143: Brixen K, Schwarz P, Mosekilde L. [Improved intervention against vitamin D deficiency and osteoporosis required]. Ugeskr Laeger. 2005 Feb 21;167(8):867. Danish. PubMed PMID: 15789835. 144: Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen PM, Blichert-Toft M. [Renal stone and primary hyperparathyroidism. Risk of renal stone before and after parathyroidectomy]. Ugeskr Laeger. 2004 Oct 11;166(42):3726-8. Danish. PubMed PMID: 15508296. 145: Jacobsen AT, Mosekilde L. [Vitamin D deficiency in ethnic minorities]. Ugeskr Laeger. 2005 Jan 3;167(1):33-4. Danish. PubMed PMID: 15675162. 146: Mosekilde L, Brot C, Hyldstrup L, Mortensen LS, Mølgård C, Rasmussen SE, Mejborn H, Rasmussen LB; Arbejdsgruppe nedsat af Danmarks Fødevareforskning. [The vitamin D status of the Danish population needs to be improved]. Ugeskr Laeger. 2005 Feb 21;167(8):895-7. Danish. PubMed PMID: 15789843. 147: Nielsen LR, Mosekilde L. [Vitamin D and breast cancer]. Ugeskr Laeger. 2007 Apr 2;169(14):1299-302. Review. Danish. PubMed PMID: 17437690. 148: Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005 Mar;62(3):265-81. Review. PubMed PMID: 15730407. 149: Mosekilde L. Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf). 2008 Jul;69(1):1-19. doi: 10.1111/j.1365-2265.2007.03162.x. Epub 2008 Jul 1. Review. PubMed PMID: 18167138. 150: Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009 Feb;94(2):351-65. doi: 10.1210/jc.2008-1760. Review. PubMed PMID: 19193910. 151: Kassem M, Mosekilde L, Rungby J, Mosekilde L, Melsen F, Eriksen EF. Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. APMIS. 1991 Mar;99(3):262-8. PubMed PMID: 2018639. 152: Abrahamsen B, Rejnmark L, Nielsen SP, Rud B, Nissen N, Mosekilde L, Bärenholdt O, Jensen JE. Ten-year prediction of osteoporosis from baseline bone mineral density: development of prognostic thresholds in healthy postmenopausal women. The Danish Osteoporosis Prevention Study. Osteoporos Int. 2006 Feb;17(2):245-51. Epub 2005 Sep 10. PubMed PMID: 16155732. 153: Abrahamsen B, Tofteng CL, Bärenholdt O, Vestergaard P, Stilgren LS, Beck-Nielsen H, Nielsen SP, Sørensen OH, Mosekilde L; Danish Osteoporosis Prevention Study. Standardization of BMD T-Scores in the first five years after the menopause: do femoral neck-equivalent and older normative range T-Scores improve diagnostic agreement? J Clin Densitom. 2003 Summer;6(2):87-95. PubMed PMID: 12794230. 154: Mosekilde L, Mosekilde L, Danielsen CC. Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone. 1987;8(2):79-85. PubMed PMID: 3593611. 155: Schwarz P, Brixen KT, Mosekilde L. [Calcium homeostasis and normal bone remodeling]. Ugeskr Laeger. 2005 Feb 21;167(8):871-3. Review. Danish. PubMed PMID: 15789837. 156: Nielsen HE, Mosekilde L, Mosekilde L, Melsen B, Christensen P, Olsen KJ, Melsen F. Relations of bone mineral content, ash weight and bone mass: implication for correction of bone mineral content for bone size. Clin Orthop Relat Res. 1980 Nov-Dec;(153):241-7. PubMed PMID: 7449223. 157: Mosekilde L. Vitamin D requirement and setting recommendation levels: long-term perspectives. Nutr Rev. 2008 Oct;66(10 Suppl 2):S170-7. doi: 10.1111/j.1753-4887.2008.00103.x. Review. PubMed PMID: 18844845. 158: Jensen KS, Mosekilde L, Mosekilde L. A model of vertebral trabecular bone architecture and its mechanical properties. Bone. 1990;11(6):417-23. PubMed PMID: 2078435. 159: Bollerslev J, Mosekilde L, Nielsen HK, Mosekilde L. Biomechanical competence of iliac crest trabecular bone in autosomal dominant osteopetrosis type I. Bone. 1989;10(3):159-64. PubMed PMID: 2803852. 160: Nørholt SE, Bjerregaard J, Mosekilde L. Maxillary distraction osteogenesis in a patient with pycnodysostosis: a case report. J Oral Maxillofac Surg. 2004 Aug;62(8):1037-40. PubMed PMID: 15278873. 161: Gravholt CH, Hjerrild BE, Naeraa RW, Engbaek F, Mosekilde L, Christiansen JS. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome. Clin Endocrinol (Oxf). 2005 May;62(5):616-22. PubMed PMID: 15853835. 162: Rolighed L, Bollerslev J, Mosekilde L. Vitamin D treatment in primary hyperparathyroidism. Curr Drug Saf. 2011 Apr;6(2):100-7. Review. PubMed PMID: 21524245. 163: Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, Wamberg L, Orskov L. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. Metabolism. 2014 Sep;63(9):1115-24. doi: 10.1016/j.metabol.2014.06.008. Epub 2014 Jun 19. PubMed PMID: 25044176. 164: Hosking DJ, O'Brien M, Brandi ML, Minne HW, Mosekilde L, Ringe J, Suppan G, Walsh JB. Declaration on Vitamin D in Osteoporosis Management: From the European Summit on the Role of Vitamin D in the Management of Osteoporosis: a MetaForum. Clin Cases Miner Bone Metab. 2007 May;4(2):163-6. PubMed PMID: 22461218; PubMed Central PMCID: PMC2781241. 165: Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention study. Aging Clin Exp Res. 2005 Apr;17(2):125-32. PubMed PMID: 15977461. 166: Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004 Mar;19(3):370-8. Epub 2003 Dec 22. PubMed PMID: 15040824. 167: Larsen ER, Mosekilde L, Foldspang A. Determinants of acceptance of a community-based program for the prevention of falls and fractures among the elderly. Prev Med. 2001 Aug;33(2 Pt 1):115-9. PubMed PMID: 11493044. 168: Larsen ER, Mosekilde L, Foldspang A. Correlates of falling during 24 h among elderly Danish community residents. Prev Med. 2004 Aug;39(2):389-98. PubMed PMID: 15226051. 169: Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res. 2003 Apr;18(4):723-9. PubMed PMID: 12674333. 170: Brixen KT, Mosekilde L. [Alendronate once a week]. Ugeskr Laeger. 2003 Jun 30;165(27):2734-9. Danish. PubMed PMID: 12886563. 171: Brixen KT, Illum NO, Hansen B, Lund AM, Mosekilde L. [Oesteogenesis imperfecta--genetics, diagnosis and medical treatment]. Ugeskr Laeger. 2007 Jan 1;169(1):30-4. Review. Danish. PubMed PMID: 17217883. 172: van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellström D, Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Weber K, Ioannidis JP, Uitterlinden AG; GENOMOS Study. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA. 2008 Mar 19;299(11):1277-90. doi: 10.1001/jama.299.11.1277. PubMed PMID: 18349089; PubMed Central PMCID: PMC3282142. 173: Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, McGuigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE, Uitterlinden AG; GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA. 2004 Nov 3;292(17):2105-14. PubMed PMID: 15523071. 174: Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO, Christiansen JS. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics. 2002 Nov;110(5):889-96. PubMed PMID: 12415026. 175: Langdahl BL, Uitterlinden AG, Ralston SH, Trikalinos TA, Balcells S, Brandi ML, Scollen S, Lips P, Lorenc R, Obermayer-Pietsch B, Reid DM, Armas JB, Arp PP, Bassiti A, Bustamante M, Husted LB, Carey AH, Pérez Cano R, Dobnig H, Dunning AM, Fahrleitner-Pammer A, Falchetti A, Karczmarewicz E, Kruk M, van Leeuwen JP, Masi L, van Meurs JB, Mangion J, McGuigan FE, Mellibovsky L, Mosekilde L, Nogués X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Ioannidis JP; APOSS investigators; DOPS investigators; EPOS investigators; EPOLOS investigators; FAMOS investigators; LASA investigators; ERGO investigators; GENOMOS Study. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone. 2008 May;42(5):969-81. doi: 10.1016/j.bone.2007.11.007. Epub 2007 Dec 3. PubMed PMID: 18284942. 176: Søgaard CH, Mosekilde L, Richards A, Mosekilde L. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients. Bone. 1994 Jul-Aug;15(4):393-9. PubMed PMID: 7917577. 177: Søgaard CH, Hermann AP, Hasling C, Mosekilde L, Mosekilde L. Spine deformity index in osteoporotic women: relations to forearm and vertebral bone mineral measurements and to iliac crest ash density. Osteoporos Int. 1994 Jul;4(4):211-9. PubMed PMID: 7949751. 178: Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P, Laurberg P, Frystyk J, Flyvbjerg A, Christiansen JS, Gravholt CH. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care. 2006 Jul;29(7):1591-8. PubMed PMID: 16801584. 179: Mosekilde L, Mosekilde L. Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone. 1990;11(2):67-73. PubMed PMID: 2357425. 180: Steiniche T, Christiansen P, Vesterby A, Ullerup R, Hessov I, Mosekilde LE, Melsen F. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment. Bone. 2000 May;26(5):535-43. PubMed PMID: 10773596. 181: Ortoft G, Mosekilde L, Hasling C, Mosekilde L. Estimation of vertebral body strength by dual photon absorptiometry in elderly individuals: comparison between measurements of total vertebral and vertebral body bone mineral. Bone. 1993 Jul-Aug;14(4):667-73. PubMed PMID: 8274311. 182: Danielsen CC, Mosekilde L, Bollerslev J, Mosekilde L. Thermal stability of cortical bone collagen in relation to age in normal individuals and in individuals with osteopetrosis. Bone. 1994 Jan-Feb;15(1):91-6. PubMed PMID: 8024858. 183: Mosekilde L, Moosgaard B, Jensen JE, Nielsen LR. [Non-skeletal effects of vitamin D deficiency]. Ugeskr Laeger. 2005 Feb 21;167(8):887-91. Review. Danish. PubMed PMID: 15789841. 184: Amstrup AK, Jakobsen NF, Lomholt S, Sikjaer T, Mosekilde L, Rejnmark L. Inverse Correlation at the Hip Between Areal Bone Mineral Density Measured by Dual-Energy X-ray Absorptiometry and Cortical Volumetric Bone Mineral Density Measured by Quantitative Computed Tomography. J Clin Densitom. 2015 Feb 17. pii: S1094-6950(15)00003-7. doi: 10.1016/j.jocd.2015.01.002. [Epub ahead of print] PubMed PMID: 25700661. 185: Vesterby A, Mosekilde L, Gundersen HJ, Melsen F, Mosekilde L, Holme K, Sørensen S. Biologically meaningful determinants of the in vitro strength of lumbar vertebrae. Bone. 1991;12(3):219-24. PubMed PMID: 1910963. 186: Søgaard CH, Mosekilde L, Richards A, Mosekilde L. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis]. Ugeskr Laeger. 1995 Apr 3;157(14):2004-8. Danish. PubMed PMID: 7740640. 187: Ueland T, Brixen K, Mosekilde L, Mosekilde L, Flyvbjerg A, Bollerslev J. Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. J Clin Endocrinol Metab. 2003 Mar;88(3):1014-8. PubMed PMID: 12629078. 188: Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone. 2005 Mar;36(3):577-83. PubMed PMID: 15777680. 189: Mosekilde L, Mosekilde L. Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone. 1986;7(3):207-12. PubMed PMID: 3768199. 190: Mosekilde L. [Is osteoporosis treatment cost-efficient?]. Ugeskr Laeger. 2002 Mar 4;164(10):1329. Danish. PubMed PMID: 11894422. 191: Mosekilde L, Mosekilde L. Iliac crest trabecular bone volume as predictor for vertebral compressive strength, ash density and trabecular bone volume in normal individuals. Bone. 1988;9(4):195-9. PubMed PMID: 3166835. 192: Mosekilde L, Viidik A, Mosekilde L. Correlation between the compressive strength of iliac and vertebral trabecular bone in normal individuals. Bone. 1985;6(5):291-5. PubMed PMID: 4096861. 193: Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013 Dec;1(4):275-83. doi: 10.1016/S2213-8587(13)70106-2. Epub 2013 Oct 7. Erratum in: Lancet Diabetes Endocrinol. 2014 Jan;2(1):e3. Dosage error in article text. PubMed PMID: 24622413. 194: Tfelt-Hansen J, Brixen KT, Mosekilde L, Schwarz P. [Parathyroid hormone-related peptide induced humoral hypercalcemia of malignancy]. Ugeskr Laeger. 2005 Feb 21;167(8):924-6. Danish. PubMed PMID: 15789851. 195: Hansen KW, Mosekilde L. [Gitelman syndrome. An overlooked disease with chronic hypomagnesemia and hypokalemia in adults]. Ugeskr Laeger. 2003 Mar 10;165(11):1123-7. Review. Danish. PubMed PMID: 12677988. 196: Mosekilde L, Pallisgaard G. [Alveolitis fibrosa: an exogenically determined syndrome?]. Ugeskr Laeger. 1978 Sep 11;140(37):2239-43. Danish. PubMed PMID: 684949. 197: Mosekilde L, Hansen HJ. [Cryptococcosis. A case of pulmonary and meningocerebral cryptococcosis treated with amphotericin and lobectomy]. Ugeskr Laeger. 1974 Dec 30;137(1):34-6. Danish. PubMed PMID: 4480323. 198: Mosekilde L, Strunge P. [Yersinia eneterocolitica arthritis and myocarditits]. Ugeskr Laeger. 1978 Jun 19;140(25):1482-3. Danish. PubMed PMID: 684885. 199: Lomholt S, Amstrup AK, Moser E, Jakobsen NF, Mosekilde L, Vestergaard P, Rejnmark L. Unexplained high BMD in DXA-scanned patients is generalized throughout the skeleton and characterized by thicker cortical and trabecular bone. Calcif Tissue Int. 2015 Apr;96(4):284-94. doi: 10.1007/s00223-015-9955-y. Epub 2015 Jan 23. PubMed PMID: 25609586. 200: Sikjaer T, Rolighed L, Hess A, Fuglsang-Frederiksen A, Mosekilde L, Rejnmark L. Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int. 2014 Jun;25(6):1717-26. doi: 10.1007/s00198-014-2677-6. Epub 2014 Apr 1. PubMed PMID: 24687385.

 

201: Við Streym S, Kristine Moller U, Rejnmark L, Heickendorff L, Mosekilde L,
Vestergaard P. Maternal and infant vitamin D status during the first 9 months of 
infant life-a cohort study. Eur J Clin Nutr. 2013 Oct;67(10):1022-8. doi:
10.1038/ejcn.2013.152. Epub 2013 Sep 4. PubMed PMID: 24002039.

202: Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. Melatonin and the skeleton. 
Osteoporos Int. 2013 Dec;24(12):2919-27. doi: 10.1007/s00198-013-2404-8. Epub
2013 May 29. Review. PubMed PMID: 23716040.

203: Harsløf T, Frost M, Nielsen TL, Husted LB, Nyegaard M, Brixen K, Børglum AD,
Mosekilde L, Andersen M, Rejnmark L, Langdahl BL. Polymorphisms of muscle genes
are associated with bone mass and incident osteoporotic fractures in Caucasians. 
Calcif Tissue Int. 2013 May;92(5):467-76. doi: 10.1007/s00223-013-9702-1. Epub
2013 Feb 1. PubMed PMID: 23370486.

204: Rejnmark L, Sikjaer T, Underbjerg L, Mosekilde L. PTH replacement therapy of
hypoparathyroidism. Osteoporos Int. 2013 May;24(5):1529-36. doi:
10.1007/s00198-012-2230-4. Epub 2012 Nov 27. Review. PubMed PMID: 23184178.

205: Møller UK, Streym S, Mosekilde L, Heickendorff L, Flyvbjerg A, Frystyk J,
Jensen LT, Rejnmark L. Changes in calcitropic hormones, bone markers and
insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a
controlled cohort study. Osteoporos Int. 2013 Apr;24(4):1307-20. doi:
10.1007/s00198-012-2062-2. Epub 2012 Aug 2. PubMed PMID: 22855199.

206: Møller UK, Streym S, Heickendorff L, Mosekilde L, Rejnmark L. Effects of
25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort
study in healthy Danish women. Eur J Clin Nutr. 2012 Jul;66(7):862-8. doi:
10.1038/ejcn.2012.18. Epub 2012 Feb 29. PubMed PMID: 22378226.

207: Vestergaard P, Hermann P, Jensen JE, Eiken P, Mosekilde L. Effects of
paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and
opioids on bone mineral density and risk of fracture: results of the Danish
Osteoporosis Prevention Study (DOPS). Osteoporos Int. 2012 Apr;23(4):1255-65.
doi: 10.1007/s00198-011-1692-0. Epub 2011 Jun 28. PubMed PMID: 21710339.

208: Møller UK, Við Streym S, Mosekilde L, Rejnmark L. Changes in bone mineral
density and body composition during pregnancy and postpartum. A controlled cohort
study. Osteoporos Int. 2012 Apr;23(4):1213-23. doi: 10.1007/s00198-011-1654-6.
Epub 2011 May 25. PubMed PMID: 21607805.

209: Vestergaard P, Schwartz F, Rejnmark L, Mosekilde L. Risk of femoral shaft
and subtrochanteric fractures among users of bisphosphonates and raloxifene.
Osteoporos Int. 2011 Mar;22(3):993-1001. doi: 10.1007/s00198-010-1512-y. Epub
2010 Dec 17. PubMed PMID: 21165600.

210: Harsløf T, Husted LB, Nyegaard M, Carstens M, Stenkjær L, Brixen K, Eiken P,
Jensen JE, Børglum AD, Mosekilde L, Rejnmark L, Langdahl BL. Polymorphisms in the
ALOX12 gene and osteoporosis. Osteoporos Int. 2011 Aug;22(8):2249-59. doi:
10.1007/s00198-010-1472-2. Epub 2010 Nov 23. PubMed PMID: 21104233.

211: Harsløf T, Tofteng CL, Husted LB, Nyegaard M, Børglum A, Carstens M,
Stenkjær L, Brixen K, Eiken P, Jensen JE, Mosekilde L, Rejnmark L, Langdahl BL.
Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene
are associated with osteoporosis. Osteoporos Int. 2011 Oct;22(10):2655-66. doi:
10.1007/s00198-010-1491-z. Epub 2010 Nov 23. PubMed PMID: 21104228.

212: Bojesen A, Birkebæk N, Kristensen K, Heickendorff L, Mosekilde L,
Christiansen JS, Gravholt CH. Bone mineral density in Klinefelter syndrome is
reduced and primarily determined by muscle strength and resorptive markers, but
not directly by testosterone. Osteoporos Int. 2011 May;22(5):1441-50. doi:
10.1007/s00198-010-1354-7. Epub 2010 Jul 24. PubMed PMID: 20658127.

213: Vestergaard P, Rejnmark L, Mosekilde L. Risk of fractures associated with
treatment for benign prostate hyperplasia in men. Osteoporos Int. 2011
Feb;22(2):731-7. doi: 10.1007/s00198-010-1320-4. Epub 2010 Jun 15. PubMed PMID:
20552327.

214: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Stroke in
relation to use of raloxifene and other drugs against osteoporosis. Osteoporos
Int. 2011 Apr;22(4):1037-45. doi: 10.1007/s00198-010-1276-4. Epub 2010 May 7.
PubMed PMID: 20449570.

215: Jones L, Thomsen JS, Barlach J, Mosekilde L, Melsen B. No influence of
alimentary zinc on the healing of calvarial defects filled with osteopromotive
substances in rats. Eur J Orthod. 2010 Apr;32(2):124-30. doi: 10.1093/ejo/cjp076.
Epub 2010 Jan 11. PubMed PMID: 20064837.

216: Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Use of
bisphosphonates and raloxifene and risk of deep venous thromboembolism and
pulmonary embolism. Osteoporos Int. 2010 Sep;21(9):1591-7. doi:
10.1007/s00198-009-1091-y. Epub 2009 Oct 27. PubMed PMID: 19859641.

217: Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS,
Rubin MR, Goltzman D, Silverberg SJ, Marx SJ, Peacock M, Mosekilde L, Bouillon R,
Lewiecki EM. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings
of the third international workshop. J Clin Endocrinol Metab. 2009
Feb;94(2):340-50. doi: 10.1210/jc.2008-1758. Review. PubMed PMID: 19193909.

218: Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L,
Vestergaard P. Global vitamin D levels in relation to age, gender, skin
pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 
2009 Jan;20(1):133-40. doi: 10.1007/s00198-008-0626-y. Epub 2008 May 6. PubMed
PMID: 18458986.

219: Rejnmark L, Vestergaard P, Hermann AP, Brot C, Eiken P, Mosekilde L. Dietary
intake of folate, but not vitamin B2 or B12, is associated with increased bone
mineral density 5 years after the menopause: results from a 10-year follow-up
study in early postmenopausal women. Calcif Tissue Int. 2008 Jan;82(1):1-11. doi:
10.1007/s00223-007-9087-0. Epub 2008 Jan 4. PubMed PMID: 18175033.

220: Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, 
Mosekilde L. Vitamin D metabolites and skeletal consequences in primary
hyperparathyroidism. Clin Endocrinol (Oxf). 2008 May;68(5):707-15. Epub 2007 Nov 
2. PubMed PMID: 17980013.

221: Jones L, Thomsen JS, Mosekilde L, Bosch C, Melsen B. Biomechanical
evaluation of rat skull defects, 1, 3, and 6 months after implantation with
osteopromotive substances. J Craniomaxillofac Surg. 2007 Dec;35(8):350-7. Epub
2007 Oct 24. PubMed PMID: 17951064.

222: Vestergaard P, Jorgensen NR, Schwarz P, Mosekilde L. Effects of treatment
with fluoride on bone mineral density and fracture risk--a meta-analysis.
Osteoporos Int. 2008 Mar;19(3):257-68. Epub 2007 Aug 15. Review. PubMed PMID:
17701094.

223: Nissen N, Gravholt CH, Abrahamsen B, Hauge EM, Jensen JE, Mosekilde L,
Brixen K. Disproportional geometry of the proximal femur in patients with Turner 
syndrome: a cross-sectional study. Clin Endocrinol (Oxf). 2007 Dec;67(6):897-903.
Epub 2007 Aug 6. PubMed PMID: 17681028.

224: Vestergaard P, Rejnmark L, Mosekilde L. Increased mortality in patients with
a hip fracture-effect of pre-morbid conditions and post-fracture complications.
Osteoporos Int. 2007 Dec;18(12):1583-93. Epub 2007 Jun 14. PubMed PMID: 17566814.

225: Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L. Plasma
1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body
mass index, plasma phosphate and renal function. Clin Endocrinol (Oxf). 2007
Jan;66(1):35-42. PubMed PMID: 17201799.

226: Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated
with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control
study. Osteoporos Int. 2007 Apr;18(4):409-17. Epub 2006 Nov 9. PubMed PMID:
17093893.

227: Rasmussen K, Larsen LP, Arveschoug A, Theil Nielsen J, Vestergaard P,
Rønning H, Mosekilde L, Christiansen P. Predictive value of parathyroid
scintigraphy in the preoperative evaluation of patients with primary
hyperparathyroidism. Scand J Surg. 2006;95(3):199-204. PubMed PMID: 17066618.

228: Vestergaard P, Jorgensen NR, Mosekilde L, Schwarz P. Effects of parathyroid 
hormone alone or in combination with antiresorptive therapy on bone mineral
density and fracture risk--a meta-analysis. Osteoporos Int. 2007 Jan;18(1):45-57.
Epub 2006 Sep 2. Review. PubMed PMID: 16951908.

229: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of
nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and
the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int. 2006
Aug;79(2):84-94. Epub 2006 Aug 15. PubMed PMID: 16927048.

230: Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2
receptor antagonists, and other antacid medications and the risk of fracture.
Calcif Tissue Int. 2006 Aug;79(2):76-83. Epub 2006 Aug 15. PubMed PMID: 16927047.

231: Vestergaard P, Rejnmark L, Mosekilde L. Methotrexate, azathioprine,
cyclosporine, and risk of fracture. Calcif Tissue Int. 2006 Aug;79(2):69-75. Epub
2006 Aug 15. PubMed PMID: 16927044.

232: Rejnmark L, Vestergaard P, Mosekilde L. Statin but not non-statin
lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Calcif Tissue Int. 2006 Jul;79(1):27-36. Epub 2006 Jul 24. PubMed PMID: 16868664.

233: Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P,
Mosekilde L. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is
associated with parathyroid adenoma secretion in primary hyperparathyroidism: a
cross-sectional study. Eur J Endocrinol. 2006 Aug;155(2):237-44. PubMed PMID:
16868136.

234: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the
use of morphine and opiates. J Intern Med. 2006 Jul;260(1):76-87. PubMed PMID:
16789982.

235: Møller UK, Ramlau-Hansen CH, Rejnmark L, Heickendorff L, Henriksen TB,
Mosekilde L. Postpartum vitamin D insufficiency and secondary hyperparathyroidism
in healthy Danish women. Eur J Clin Nutr. 2006 Oct;60(10):1214-21. Epub 2006 May 
24. PubMed PMID: 16721399.

236: Rejnmark L, Lauridsen AL, Brot C, Vestergaard P, Heickendorff L, Nexo E,
Mosekilde L. Vitamin D and its binding protein Gc: long-term variability in peri-
and postmenopausal women with and without hormone replacement therapy. Scand J
Clin Lab Invest. 2006;66(3):227-38. PubMed PMID: 16714251.

237: Rejnmark L, Vestergaard P, Cha